可視化

発行年ごと論文数

著者正規化top50

著者正規化top50の共著関係

タイトル語top50

タイトル語top50の共起

ジャーナル一覧

ジャーナル分野比率


論文リスト

doi title author source_title year
192 10.1001/jamaoncol.2018.0013 Safety And Efficacy Of Pembrolizumab Monotherapy In Patients With Previously Treated Advanced Gastric And Gastroesophageal Junction Cancer Fuchs, Charles S.; Doi, Toshihiko; Jang, Raymond W.; Muro, Kei; Satoh, Taroh; Machado, Manuela; Sun, Weijing; Jalal, Shadia I.; Shah, Manish A.; Metges, Jean-Phillipe; Garrido, Marcelo; Golan, Talia; Mandala, Mario; Wainberg, Zev A.; Catenacci, Daniel V.; Ohtsu, Atsushi; Shitara, Kohei; Geva, Ravit; Bleeker, Jonathan; Ko, Andrew H.; Ku, Geoffrey; Philip, Philip; Enzinger, Peter C.; Bang, Yung-Jue; Levitan, Diane; Wang, Jiangdian; Rosales, Minori; Dalal, Rita P.; Yoon, Harry H. Jama Oncology 2018
195 10.1001/jamaoncol.2018.2969 Assessment Of Resistance Mechanisms And Clinical Implications In Patients Withegfrt790M<U+2013>Positive Lung Cancer And Acquired Resistance To Osimertinib Oxnard, Geoffrey R.; Hu, Yuebi; Mileham, Kathryn F.; Husain, Hatim; Costa, Daniel B.; Tracy, Philip; Feeney, Nora; Sholl, Lynette M.; Dahlberg, Suzanne E.; Redig, Amanda J.; Kwiatkowski, David J.; Rabin, Michael S.; Paweletz, Cloud P.; Thress, Kenneth S.; Janne, Pasi A. Jama Oncology 2018
198 10.1001/jamaoncol.2018.4224 Long-Term Clinical Outcomes And Biomarker Analyses Of Atezolizumab Therapy For Patients With Metastatic Triple-Negative Breast Cancer Jama Oncology 2019
201 10.1001/jamaoncol.2018.5152 Atezolizumab Plus Nab-Paclitaxel In The Treatment Of Metastatic Triple-Negative Breast Cancer With 2-Year Survival Follow-Up Adams, Sylvia; Diamond, Jennifer R.; Hamilton, Erika; Pohlmann, Paula R.; Tolaney, Sara M.; Chang, Ching-Wei; Zhang, Wei; Iizuka, Koho; Foster, Paul G.; Molinero, Luciana; Funke, Roel; Powderly, John Jama Oncology 2019
203 10.1001/jamaoncol.2018.5441 Efficacy And Safety Of Pembrolizumab For Heavily Pretreated Patients With Advanced, Metastatic Adenocarcinoma Or Squamous Cell Carcinoma Of The Esophagus Shah, Manish A.; Kojima, Takashi; Hochhauser, Daniel; Enzinger, Peter; Raimbourg, Judith; Hollebecque, Antoine; Lordick, Florian; Kim, Sung-Bae; Tajika, Masahiro; Kim, Heung Tae; Lockhart, A. Craig; Arkenau, Hendrik-Tobias; El-Hajbi, Farid; Gupta, Mukul; Pfeiffer, Per; Liu, Qi; Lunceford, Jared; Kang, S. Peter; Bhagia, Pooja; Kato, Ken Jama Oncology 2019
207 10.1001/jamaoncol.2018.6258 Efficacy And Safety Of Avelumab For Patients With Recurrent Or Refractory Ovarian Cancer Disis, Mary L.; Taylor, Matthew H.; Kelly, Karen; Beck, J. Thaddeus; Gordon, Michael; Moore, Kathleen M.; Patel, Manish R.; Chaves, Jorge; Park, Haeseong; Mita, Alain C.; Hamilton, Erika P.; Annunziata, Christina M.; Grote, Hans Juergen; Von Heydebreck, Anja; Grewal, Jaspreet; Chand, Vikram; Gulley, James L. Jama Oncology 2019
213 10.1001/jamaoncol.2019.1029 Open-Label Clinical Trial Of Niraparib Combined With Pembrolizumab For Treatment Of Advanced Or Metastatic Triple-Negative Breast Cancer Vinayak, Shaveta; Tolaney, Sara M.; Schwartzberg, Lee; Mita, Monica; Mccann, Georgia; Tan, Antoinette R.; Wahner-Hendrickson, Andrea E.; Forero, Andres; Anders, Carey; Wulf, Gerburg M.; Dillon, Patrick; Lynce, Filipa; Zarwan, Corrine; Erban, John K.; Zhou, Yinghui; Buerstatte, Nathan; Graham, Julie R.; Arora, Sujata; Dezube, Bruce J.; Telli, Melinda L. Jama Oncology 2019
214 10.1001/jamaoncol.2019.1048 Single-Arm Phases 1 And 2 Trial Of Niraparib In Combination With Pembrolizumab In Patients With Recurrent Platinum-Resistant Ovarian Carcinoma Jama Oncology 2019
217 10.1001/jamaoncol.2019.3343 Assessment Of Combined Nivolumab And Bevacizumab In Relapsed Ovarian Cancer Liu, Joyce F.; Herold, Christina; Gray, Kathryn P.; Penson, Richard T.; Horowitz, Neil; Konstantinopoulos, Panagiotis A.; Castro, Cesar M.; Hill, Sarah J.; Curtis, Jennifer; Luo, Weixiu; Matulonis, Ursula A.; Cannistra, Stephen A.; Dizon, Don S. Jama Oncology 2019
220 10.1001/jamaoncol.2019.6650 Effect Of Pembrolizumab Plus Neoadjuvant Chemotherapy On Pathologic Complete Response In Women With Early-Stage Breast Cancer Jama Oncology 2020
227 10.1001/jamaoncol.2020.3370 Efficacy And Safety Of Pembrolizumab Or Pembrolizumab Plus Chemotherapy Vs Chemotherapy Alone For Patients With First-Line, Advanced Gastric Cancer Shitara, Kohei; Van Cutsem, Eric; Bang, Yung-Jue; Fuchs, Charles; Wyrwicz, Lucjan; Lee, Keun-Wook; Kudaba, Iveta; Garrido, Marcelo; Chung, Hyun Cheol; Lee, Jeeyun; Castro, Hugo Raul; Mansoor, Wasat; Braghiroli, Maria Ignez; Karaseva, Nina; Caglevic, Christian; Villanueva, Luis; Goekkurt, Eray; Satake, Hironaga; Enzinger, Peter; Alsina, Maria; Benson, Al; Chao, Joseph; Ko, Andrew H.; Wainberg, Zev A.; Kher, Uma; Shah, Sukrut; Kang, S. Peter; Tabernero, Josep Jama Oncology 2020
2002 10.1002/gcc.22671 A Novel Group Of Spindle Cell Tumors Defined By S100 And Cd34 Co-Expression Shows Recurrent Fusions Involving Raf1, Braf, And Ntrk1/2 Genes Suurmeijer, Albert J. H.; Dickson, Brendan C., 0000-0003-2269-6216; Swanson, David; Zhang, Lei; Sung, Yun-Shao; Cotzia, Paolo; Fletcher, Christopher D. M.; Antonescu, Cristina R., 0000-0002-9717-8205 Genes, Chromosomes And Cancer 2018
2567 10.1007/s10120-018-00909-5 Pembrolizumab Alone Or In Combination With Chemotherapy As First-Line Therapy For Patients With Advanced Gastric Or Gastroesophageal Junction Adenocarcinoma: Results From The Phase Ii Nonrandomized Keynote-059 Study Bang, Yung-Jue; Kang, Yoon-Koo; Catenacci, Daniel V.; Muro, Kei; Fuchs, Charles S.; Geva, Ravit; Hara, Hiroki; Golan, Talia; Garrido, Marcelo; Jalal, Shadia I.; Borg, Christophe; Doi, Toshihiko; Yoon, Harry H.; Savage, Mary J.; Wang, Jiangdian; Dalal, Rita P.; Shah, Sukrut; Wainberg, Zev A.; Chung, Hyun Cheol Gastric Cancer 2019
3136 10.1016/j.annonc.2020.01.013 Tatton: A Multi-Arm, Phase Ib Trial Of Osimertinib Combined With Selumetinib, Savolitinib, Or Durvalumab In Egfr-Mutant Lung Cancer Oxnard, G.R.; Yang, J.C.-H.; Yu, H.; Kim, S.-W.; Saka, H.; Horn, L.; Goto, K.; Ohe, Y.; Mann, H.; Thress, K.S.; Frigault, M.M.; Vishwanathan, K.; Ghiorghiu, D.; Ramalingam, S.S.; Ahn, M.-J. Annals Of Oncology 2020
3137 10.1016/j.annonc.2020.01.072 Pembrolizumab Plus Chemotherapy As Neoadjuvant Treatment Of High-Risk, Early-Stage Triple-Negative Breast Cancer: Results From The Phase 1B Open-Label, Multicohort Keynote-173 Study Schmid, P., 0000-0001-9817-5228; Salgado, R.; Park, Y.H.; Munoz-Couselo, E.; Kim, S.B.; Sohn, J.; Im, S.-A.; Foukakis, T.; Kuemmel, S.; Dent, R.; Yin, L.; Wang, A.; Tryfonidis, K.; Karantza, V.; Cortes, J.; Loi, S. Annals Of Oncology 2020
3143 10.1016/j.annonc.2020.04.478 Updated Overall Survival And Final Progression-Free Survival Data For Patients With Treatment-Naive Advanced Alk-Positive Non-Small-Cell Lung Cancer In The Alex Study Mok, T.; Camidge, D.R.; Gadgeel, S.M.; Rosell, R.; Dziadziuszko, R.; Kim, D.-W.; Perol, M.; Ou, S.-H.I.; Ahn, J.S.; Shaw, A.T.; Bordogna, W.; Smoljanovi<U+0107>, V.; Hilton, M.; Ruf, T.; Noe, J.; Peters, S. Annals Of Oncology 2020
3146 10.1016/j.annonc.2020.08.2102 Esmo Recommendations On Predictive Biomarker Testing For Homologous Recombination Deficiency And Parp Inhibitor Benefit In Ovarian Cancer Miller, R.E.; Leary, A.; Scott, C.L.; Serra, V.; Lord, C.J.; Bowtell, D.; Chang, D.K.; Garsed, D.W.; Jonkers, J.; Ledermann, J.A.; Nik-Zainal, S.; Ray-Coquard, I.; Shah, S.P.; Matias-Guiu, X.; Swisher, E.M.; Yates, L.R. Annals Of Oncology 2020
3148 10.1016/j.annonc.2020.08.2296 Lba6_Pr Nivolumab (Nivo) Plus Chemotherapy (Chemo) Versus Chemo As First-Line (1L) Treatment For Advanced Gastric Cancer/Gastroesophageal Junction Cancer (Gc/Gejc)/Esophageal Adenocarcinoma (Eac): First Results Of The Checkmate 649 Study Moehler, M.; Shitara, K.; Garrido, M.; Salman, P.; Shen, L.; Wyrwicz, L.; Yamaguchi, K.; Skoczylas, T.; Campos Bragagnoli, A.; Liu, T.; Schenker, M.; Yanez, P.; Tehfe, M.; Poulart, V.; Cullen, D.; Lei, M.; Kondo, K.; Li, M.; Ajani, J.A.; Janjigian, Y.Y. Annals Of Oncology 2020
3149 10.1016/j.annonc.2020.08.2298 Lba8_Pr Pembrolizumab Plus Chemotherapy Versus Chemotherapy As First-Line Therapy In Patients With Advanced Esophageal Cancer: The Phase 3 Keynote-590 Study Kato, K.; Sun, J-M.; Shah, M.A.; Enzinger, P.C.; Adenis, A.; Doi, T.; Kojima, T.; Metges, J-P.; Li, Z.; Kim, S-B.; Cho, B.C. Chul; Mansoor, W.; Li, S-H.; Sunpaweravong, P.; Maqueda, M.A.; Goekkurt, E.; Liu, Q.; Shah, S.; Bhagia, P.; Shen, L. Annals Of Oncology 2020
3907 10.1016/j.ccell.2019.09.001 Pan-Cancer Landscape And Analysis Of Erbb2 Mutations Identifies Poziotinib As A Clinically Active Inhibitor And Enhancer Of T-Dm1 Activity Robichaux, Jacqulyne P.; Elamin, Yasir Y.; Vijayan, R.S.K.; Nilsson, Monique B.; Hu, Lemei; He, Junqin; Zhang, Fahao; Pisegna, Marlese; Poteete, Alissa; Sun, Huiying; Li, Shuai; Chen, Ting; Han, Han; Negrao, Marcelo Vailati; Ahnert, Jordi Rodon; Diao, Lixia; Wang, Jing; Le, Xiuning; Meric-Bernstam, Funda; Routbort, Mark; Roeck, Brent; Yang, Zane; Raymond, Victoria M.; Lanman, Richard B.; Frampton, Garrett M.; Miller, Vincent A.; Schrock, Alexa B.; Albacker, Lee A.; Wong, Kwok-Kin; Cross, Jason B.; Heymach, John V. Cancer Cell 2019
4462 10.1016/j.celrep.2018.11.054 Parp Inhibition Elicits Sting-Dependent Antitumor Immunity In Brca1-Deficient Ovarian Cancer Ding, Liya; Kim, Hye-Jung; Wang, Qiwei; Kearns, Michael; Jiang, Tao; Ohlson, Carolynn E.; Li, Ben B.; Xie, Shaozhen; Liu, Joyce F.; Stover, Elizabeth H.; Howitt, Brooke E.; Bronson, Roderick T.; Lazo, Suzan; Roberts, Thomas M.; Freeman, Gordon J.; Konstantinopoulos, Panagiotis A.; Matulonis, Ursula A.; Zhao, Jean J. Cell Reports 2018
5382 10.1016/j.ebiom.2019.01.019 Prediction Of Alk Mutations Mediating Alk-Tkis Resistance And Drug Re-Purposing To Overcome The Resistance Okada, Koutaroh; Araki, Mitsugu; Sakashita, Takuya; Ma, Biao; Kanada, Ryo; Yanagitani, Noriko; Horiike, Atsushi; Koike, Sumie; Oh-Hara, Tomoko; Watanabe, Kana; Tamai, Keiichi; Maemondo, Makoto; Nishio, Makoto; Ishikawa, Takeshi, 0000-0002-3187-1381; Okuno, Yasushi; Fujita, Naoya; Katayama, Ryohei, 0000-0001-7394-895X Ebiomedicine 2019
7592 10.1016/j.jmoldx.2019.03.008 Detection Of Tumor Ntrk Gene Fusions To Identify Patients Who May Benefit From Tyrosine Kinase (Trk) Inhibitor Therapy Hsiao, Susan J., 0000-0002-0319-4969; Zehir, Ahmet, 0000-0001-5406-4104; Sireci, Anthony N.; Aisner, Dara L. The Journal Of Molecular Diagnostics 2019
7887 10.1016/j.jtho.2019.02.001 Osimertinib Plus Durvalumab Versus Osimertinib Monotherapy In Egfr T790M<U+2013>Positive Nsclc Following Previous Egfr Tki Therapy: Caural Brief Report Yang, James Chih-Hsin; Shepherd, Frances A.; Kim, Dong-Wan; Lee, Gyeong-Won; Lee, Jong Seok; Chang, Gee-Chen; Lee, Sung Sook; Wei, Yu-Feng; Lee, Yun Gyoo; Laus, Gianluca; Collins, Barbara; Pisetzky, Francesca; Horn, Leora Journal Of Thoracic Oncology 2019
7888 10.1016/j.jtho.2019.03.007 Updated Efficacy And Safety Data And Impact Of The Eml4-Alk Fusion Variant On The Efficacy Of Alectinib In Untreated Alk-Positive Advanced Non<U+2013>Small Cell Lung Cancer In The Global Phase Iii Alex Study Camidge, D. Ross; Dziadziuszko, Rafal; Peters, Solange; Mok, Tony; Noe, Johannes; Nowicka, Malgorzata; Gadgeel, Shirish M.; Cheema, Parneet; Pavlakis, Nick; De Marinis, Filippo; Cho, Byoung Chul; Zhang, Li; Moro-Sibilot, Denis; Liu, Ting; Bordogna, Walter; Balas, Bogdana; Muller, Barbara; Shaw, Alice T. Journal Of Thoracic Oncology 2019
7889 10.1016/j.jtho.2019.04.026 Durvalumab In Combination With Olaparib In Patients With Relapsed Sclc: Results From A Phase Ii Study Thomas, Anish; Vilimas, Rasa; Trindade, Christopher; Erwin-Cohen, Rebecca; Roper, Nitin; Xi, Liqiang; Krishnasamy, Venkatesh; Levy, Elliot; Mammen, Andy; Nichols, Samantha; Chen, Yuanbin; Velcheti, Vamsidhar; Yin, Faye; Szabo, Eva; Pommier, Yves; Steinberg, Seth M.; Trepel, Jane B.; Raffeld, Mark; Young, Howard A.; Khan, Javed; Hewitt, Stephen; Lee, Jung-Min Journal Of Thoracic Oncology 2019
7890 10.1016/j.jtho.2019.06.002 Concurrent Rb1 And Tp53 Alterations Define A Subset Of Egfr-Mutant Lung Cancers At Risk For Histologic Transformation And Inferior Clinical Outcomes Journal Of Thoracic Oncology 2019
7896 10.1016/j.jtho.2019.12.129 Efficacy And Safety Of Anti<U+2013>Pd-1 Immunotherapy In Patients With Advanced Nsclc With Braf, Her2, Or Met Mutations Or Ret Translocation: Gfpc 01-2018 Guisier, Florian, 0000-0002-8166-7303; Dubos-Arvis, Catherine; Vinas, Florent; Doubre, Helene; Ricordel, Charles; Ropert, Stanislas; Janicot, Henri; Bernardi, Marie; Fournel, Pierre; Lamy, Regine; Perol, Maurice; Dauba, Jerome; Gonzales, Gilles; Falchero, Lionel; Decroisette, Chantal; Assouline, Pascal; Chouaid, Christos; Bylicki, Olivier Journal Of Thoracic Oncology 2020
7897 10.1016/j.jtho.2020.01.006 Ret Solvent Front Mutations Mediate Acquired Resistance To Selective Ret Inhibition In Ret-Driven Malignancies Solomon, Benjamin J.; Tan, Lavinia; Lin, Jessica J.; Wong, Stephen Q.; Hollizeck, Sebastian; Ebata, Kevin; Tuch, Brian B.; Yoda, Satoshi; Gainor, Justin F.; Sequist, Lecia V.; Oxnard, Geoffrey R.; Gautschi, Oliver; Drilon, Alexander; Subbiah, Vivek; Khoo, Christine; Zhu, Edward Y.; Nguyen, Michele; Henry, Dahlia; Condroski, Kevin R.; Kolakowski, Gabrielle R.; Gomez, Eliana; Ballard, Joshua; Metcalf, Andrew T.; Blake, James F.; Dawson, Sarah-Jane; Blosser, Wayne; Stancato, Louis F.; Brandhuber, Barbara J.; Andrews, Steve; Robinson, Bruce G.; Rothenberg, S. Michael Journal Of Thoracic Oncology 2020
10054 10.1016/j.ygyno.2018.11.017 Pembrolizumab In Patients With Programmed Death Ligand 1<U+2013>Positive Advanced Ovarian Cancer: Analysis Of Keynote-028 Varga, Andrea; Piha-Paul, Sarina; Ott, Patrick A.; Mehnert, Janice M.; Berton-Rigaud, Dominique; Morosky, Anne; Yang, Ping; Ruman, Jane; Matei, Daniela Gynecologic Oncology 2019
10086 10.1016/s0140-6736(18)31257-1 Pembrolizumab Versus Paclitaxel For Previously Treated, Advanced Gastric Or Gastro-Oesophageal Junction Cancer (Keynote-061): A Randomised, Open-Label, Controlled, Phase 3 Trial Shitara, Kohei; Ozguro<U+011F>lu, Mustafa; Bang, Yung-Jue; Di Bartolomeo, Maria; Mandala, Mario; Ryu, Min-Hee; Fornaro, Lorenzo; Olesi<U+0144>ski, Tomasz; Caglevic, Christian; Chung, Hyun C; Muro, Kei; Goekkurt, Eray; Mansoor, Wasat; Mcdermott, Raymond S; Shacham-Shmueli, Einat; Chen, Xinqun; Mayo, Carlos; Kang, S Peter; Ohtsu, Atsushi; Fuchs, Charles S; Lerzo, Guillermo; O’Connor, Juan Manuel; Mendez, Guillermo Ariel; Lynam, James; Tebbutt, Niall; Wong, Mark; Strickland, Andrew; Karapetis, Chris; Goldstein, David; Vasey, Paul; Van Laethem, Jean-Luc; Van Cutsem, Eric; Berry, Scott; Vincent, Mark; Muller, Bettina; Rey, Felipe; Zambrano, Angela; Guerra, Joaquin; Krogh, Merete; Baeksgaard, Lene; Yilmaz, Mette; Elme, Anneli; Magi, Andrus; Auvinen, Paivi; Alanko, Tuomo; Moehler, Markus; Kunzmann, Volker; Seufferlein, Thomas; Thuss-Patience, Peter; Goekkurt, Eray; Hoehler, Thomas; Haag, Georg; Al-Batran, Salah-Eddin; Castro, Hugo; Lopez, Karla; Aguilar Vasquez, Mynor; Sandoval, Mario; Lam, Ka On; Cuffe, Sinead; Kelly, Cathy; Geva, Ravit; Shacham-Shmueli, Einat; Hubert, Ayala; Beny, Alex; Brenner, Baruch; Giuseppe, Aprile; Falcone, Alfredo; Maiello, Evaristo; Passalacqua, Rodolfo; Montesarchio, Vincenzo; Hara, Hiroki; Chin, Keisho; Nishina, Tomohiro; Komatsu, Yoshito; Machida, Nozumo; Hironaka, Shuichi; Satoh, Taroh; Tamura, Takao; Sugimoto, Naotaoshi; Cho, Haruhiko; Omuro, Yashushi; Kato, Ken; Goto, Masahiro; Hyodo, Ichinosuke; Yoshida, Kazuhiro; Baba, Hideo; Esaki, Taito; Furuse, Junji; Wan Mohammed, Wan Zamaniah; Hernandez Hernandez, Carlos; Casas Garcia, Juan; Dominguez Andrade, Adriana; Clarke, Katriona; Hjortland, Geir; Glenjen, Nils; Kubiatowski, Tomasz; Jacek, Jassem; Wojtukiewicz, Marek; Lazarev, Sergey; Lancukhay, Yuri; Afanasayev, Sergey; Moiseyenko, Vladimir; Kostorov, Vladimir; Protsenko, Svetlana; Shirinkin, Vadim; Sakaeva, Dina; Fadeeva, Natalia; Yong, Wei Peng; Ng, Chau Hsien Matthew; Robertson, Barbara; Rapaport, Bernardo; Cohen, Graham; Dreosti, Lydia; Ruff, Paul; Jacobs, Conrad; Landers, Gregory; Szpak, Waldemar; Roh, Sang-Young; Lee, Jeeyun; Kim, Yeul Hong; Bang, Yung-Jue; Chung, Hyun Cheol; Ryu, Min-Hee; Alsina Maqueda, Maria; Longo Munoz, Federico; Cervantes Aguilar, Andres; Aranda Aguilar, Enrique; Garcia Alfonso, Pilar; Rivera, Fernando; Feliu Batle, Jaime; Pazo Cid, Roberto; Yeh, Kun-Huei; Chen, Jen-Shi; Chao, Yee; Yen, Chia-Jui; Ozguro<U+011F>lu, Mustafa; Kara, Oguz; Yalcin, Suayib; Hochhauser, Daniel; Chau, Ian; Benson, Al; Shankaran, Veena; Shaib, Walid; Philip, Philip; Sharma, Vivek; Siegel, Robert; Sun, Weijing; Wainberg, Zev; George, Ben; Bullock, Andrea; Myrick, Samuel; Faruol, Josephine; Siegel, Richard; Larson, Timothy; Becerra, Carlos; Ratnam, Suresh; Richards, Donald A.; Riche, Stephen L. The Lancet 2018
10116 10.1016/s0140-6736(19)30650-6 6 Versus 12 Months Of Adjuvant Trastuzumab For Her2-Positive Early Breast Cancer (Persephone): 4-Year Disease-Free Survival Results Of A Randomised Phase 3 Non-Inferiority Trial Earl, Helena M; Hiller, Louise; Vallier, Anne-Laure; Loi, Shrushma; Mcadam, Karen; Hughes-Davies, Luke; Harnett, Adrian N; Ah-See, Mei-Lin; Simcock, Richard; Rea, Daniel; Raj, Sanjay; Woodings, Pamela; Harries, Mark; Howe, Donna; Raynes, Kerry; Higgins, Helen B; Wilcox, Maggie; Plummer, Chris; Mansi, Janine; Gounaris, Ioannis; Mahler<U+2013>Araujo, Betania; Provenzano, Elena; Chhabra, Anita; Abraham, Jean E; Caldas, Carlos; Hall, Peter S; Mccabe, Christopher; Hulme, Claire; Miles, David; Wardley, Andrew M; Cameron, David A; Dunn, Janet A; Agarwal, Roshan; Algurafi, Hafiz; Allerton, Rozenn; Archer, Caroline; Armstrong, Anne; Bale, Catherine; Barraclough, Lisa; Barthakur, Urmila; Bedi, Carolyn; Benstead, Kim; Bloomfield, David; Bowen, Rebecca; Bradley, Chris; Brown, Jane; Butt, Mohammad; Churn, Mark; Cleator, Susan; Cliff, Joanne; Crellin, Perric; Daly, Margaret; De Silva-Minor, Shiroma; Dhadda, Amandeep; Din, Omar; Down, Sue; Earl, Helena; Eaton, David; Eichholz, Andrew; Epurescu, Daniel; Goh, Chee; Goodman, Andrew; Grieve, Robert; Hadaki, Maher; Harper-Wynne, Catherine; Harries, Mark; Hayward, Larry; Humphreys, Alison; Innes, Helen; Jafri, Mariam; Jegannathen, Apurna; Kelleher, Muireann; Kristeleit, Hartmut; Lee, Daniela; Lupton, Susan; Macgregor, Carol; Malik, Zafar; Mansi, Janine; Marshall, Jennifer; Mcadam, Karen; Mcgolick, Trevor; Mehra, Rakesh; Miles, David; Mithal, Natasha; Moss, Charlotte; Moss, Aian; Mukesh, Mukesh; Neal, Anthony; Nelmes, Daniel; Neville-Webbe, Helen; Newby, Jacqueline; O’Reilly, Susan; Ostler, Peter; Persic, Mojca; Pettit, Laura; Raj, Sanjay; Raja, Fharat; Rea, Daniel; Reed, Catherine; Rigg, Anne; Roe, Helen; Shah, Nihal; Simmonds, Peter; Sims, Eliot; Smith, Sarah; Storey, Nicola; Taylor, Wendy; Thanvi, Narottam; Tipples, Karen; Vaidya, Jayant; Varughese, Mohini; Vinayan, Anup; Walji, Nawaz; Waters, Simon; Woodings, Pamela; Wright, Kathryn; Yahya, Sundus The Lancet 2019
10135 10.1016/s0140-6736(19)32259-7 Weekly Dose-Dense Chemotherapy In First-Line Epithelial Ovarian, Fallopian Tube, Or Primary Peritoneal Carcinoma Treatment (Icon8): Primary Progression Free Survival Analysis Results From A Gcig Phase 3 Randomised Controlled Trial Clamp, Andrew R; James, Elizabeth C; Mcneish, Iain A; Dean, Andrew; Kim, Jae-Weon; O’Donnell, Dearbhaile M; Hook, Jane; Coyle, Christopher; Blagden, Sarah; Brenton, James D; Naik, Raj; Perren, Tim; Sundar, Sudha; Cook, Adrian D; Gopalakrishnan, Gosala S; Gabra, Hani; Lord, Rosemary; Dark, Graham; Earl, Helena M; Hall, Marcia; Banerjee, Susana; Glasspool, Rosalind M; Jones, Rachel; Williams, Sarah; Swart, Ann Marie; Stenning, Sally; Parmar, Mahesh; Kaplan, Richard; Ledermann, Jonathan A The Lancet 2019
10214 10.1016/s0140-6736(20)31953-x Neoadjuvant Atezolizumab In Combination With Sequential Nab-Paclitaxel And Anthracycline-Based Chemotherapy Versus Placebo And Chemotherapy In Patients With Early-Stage Triple-Negative Breast Cancer (Impassion031): A Randomised, Double-Blind, Phase 3 Trial Mittendorf, Elizabeth A; Zhang, Hong; Barrios, Carlos H; Saji, Shigehira; Jung, Kyung Hae; Hegg, Roberto; Koehler, Andreas; Sohn, Joohyuk; Iwata, Hiroji; Telli, Melinda L; Ferrario, Cristiano; Punie, Kevin; Penault-Llorca, Frederique; Patel, Shilpen; Duc, Anh Nguyen; Liste-Hermoso, Mario; Maiya, Vidya; Molinero, Luciana; Chui, Stephen Y; Harbeck, Nadia The Lancet 2020
10221 10.1016/s0140-6736(20)32531-9 Pembrolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy For Previously Untreated Locally Recurrent Inoperable Or Metastatic Triple-Negative Breast Cancer (Keynote-355): A Randomised, Placebo-Controlled, Double-Blind, Phase 3 Clinical Trial Cortes, Javier; Cescon, David W; Rugo, Hope S; Nowecki, Zbigniew; Im, Seock-Ah; Yusof, Mastura Md; Gallardo, Carlos; Lipatov, Oleg; Barrios, Carlos H; Holgado, Esther; Iwata, Hiroji; Masuda, Norikazu; Otero, Marco Torregroza; Gokmen, Erhan; Loi, Sherene; Guo, Zifang; Zhao, Jing; Aktan, Gursel; Karantza, Vassiliki; Schmid, Peter; Luis, Fein; Gonzalo, Gomez Abuin; Diego, Kaen; Ruben, Kowalwszyn; Matias, Molina; Mirta, Varela; Sally, Baron-Hay; Stephen, Begbie; Philip, Clingan; Sherene, Loi; Dhanusha, Sabanathan; Andrea, Gombos; Donatienne, Taylor; Carlos, Barrios; Leandro, Brust; Fabiano, Costa; Ruffo, De Freitas Junior; Roberto, Hegg; Domicio Carvalho, Lacerda; Fernando Cezar Toniazzi, Lissa; Roberto Odebrecht, Rocha; Antonio Orlando, Scalabrini Neto; Felipe, Silva; David, Cescon; Danielle, Charpentier; Cristiano, Ferrario; Xinni, Song; Joanne, Yu; Alejandro, Acevedo; Carlos, Gallardo; Claudio, Salas; Cesar, Sanchez; Eduardo, Yanez; Alvaro, Gomez Diaz; Jesus, Sanchez; Petra, Holeckova; Zdenek, Kral; Bohuslav, Melichar; Katarina, Petrakova; Jana, Prausova; Vesna, Glavicic; Erik, Jakobsen; Jeanette, Jensen; Soren, Linnet; Tamas, Lorincz; Herve, Bonnefoi; Isabelle, Desmoulins; Anthony, Goncalves; Anne-Claire, Hardy-Bessard; Luis, Teixeira; Jens-Uwe, Blohmer; Peter, Fasching; Dirk, Forstmeyer; Nadia, Harbeck; Jens, Huober; Anna, Kaczerowsky Flores De Sousa; Christian, Kurbacher; Sibylle, Loibl; Diana, Lueftner; Tjoung-Won, Park-Simon; Raquel Von, Schumann; Pauline, Wimberger; Louis, Chow; Ava, Kwong; Kai Cheong Roger, Ngan; Peter, Arkosy; Tibor, Csoszi; Zsuzsanna, Kahan; Laszlo, Landherr; Karoly, Mahr; Gabor, Rubovszky; John, Crown; Catherine, Kelly; Seamus, O’Reilly; Saverio, Cinieri; Antonietta, Dalessio; Enrico, Ricevuto; Tomoyuki, Aruga; Takaaki, Fujii; Kenichi, Inoue; Takashi, Ishikawa; Yoshinori, Ito; Tsutomu, Iwasa; Hiroji, Iwata; Yoshimasa, Kosaka; Koji, Matsumoto; Yasuo, Miyoshi; Hirofumi, Mukai; Seigo, Nakamura; Naoki, Niikura; Shoichiro, Ohtani; Akihiko, Osaki; Yasuaki, Sagara; Eiji, Suzuki; Masato, Takahashi; Yuko, Tanabe; Kenji, Tamura; Koichiro, Tsugawa; Junichiro, Watanabe; Naohito, Yamamoto; Yutaka, Yamamoto; Teruo, Yamauchi; Anita, Bustam; Mastura, Md Yusof; Angel, Gomez Villanueva; Alejandro, Juarez Ramiro; Jorge, Martinez Rodriguez; Flavia, Morales-Vasquez; Jessica, Reyes Contreras; Karin, Beelen; Vivianne, Tjan-Heijnen; David, Porter; Ewa, Chmielowska; Ewa, Nowakowska-Zajdel; Zbigniew, Nowecki; Barbara, Radecka; Joanna, Streb; Cezary, Szczylik; Rafal, Tarnawski; Bogdan, Zurawski; Alexander, Arkhipov; Natalia, Fadeeva; Oleg, Lipatov; Andrey, Meshcheryakov; Vladimir, Moiseyenko; Guzel, Mukhametshina; Jin Hee, Ahn; Seock-Ah, Im; Keun Seok, Lee; Kwong Hwa, Park; Yeon Hee, Park; Begona, Bermejo De Las Heras; Javier, Cortes; Josefina, Cruz Jurado; Luis, De La Cruz Merino; Jose, Garcia Saenz; Maria, Gion; Esther, Holgado; Esther, Zamora Adelantado; Chien-Ting, Liu; Mei-Ching, Liu; Chiun-Sheng, Huang; Chao-Jung, Tsao; Ling-Ming, Tseng; Cagatay, Arslan; Gul, Basaran; Irfan, Cicin; Erhan, Gokmen; Seyda, Gunduz; Nil, Molinas Mandel; Mustafa, Ozguroglu; Ozgur, Ozyilkan; Sinan, Yavuz; Steve, Chan; Janine, Graham; Iain, Macpherson; Peter, Schmid; Nicholas, Turner; Mark, Tuthill; Christopher, Twelves; Duncan, Wheatley; Hryhoriy, Adamchuk; Oleksandr, Berzoy; Igor, Bondarenko; Oleksii, Kolesnik; Olena, Kolesnik; Hanna, Komisarenko; Anna, Kryzhanivska; Iurii, Leshchenko; Alla, Nasonova; Natalya, Otchenash; Olga, Ponomarova; Andrii, Rusyn; Sergii, Shevnya; Yaroslav, Shparyk; Dmytro, Trukhin; Grygorii, Ursol; Ihor, Vynnychenko; Sibel, Blau; Madhu, Chaudhry; Michael, Chung; Patrick, Cobb; Scott, Cole; Jennifer, Diamond; Keerthi, Gogineni; Jeffrey, Hargis; Kent, Hoskins; William, Irvin; Randa, Loutfi; Janice, Lu; Raul, Mena; Susan, Moore; Rita, Nanda; Ira, Oliff; Coral, Omene; Timothy, Panella; Amit, Panwalkar; Brian, Patson; Hope, Rugo; Irina, Rybalova; Michael, Schleider; Robert, Siegel; Michael, Simon; Laura, Stampleman; Bradley, Sumrall; Michaela, Tsai; Frances, Valdes-Albini The Lancet 2020
10240 10.1016/s0140-6736(21)00797-2 First-Line Nivolumab Plus Chemotherapy Versus Chemotherapy Alone For Advanced Gastric, Gastro-Oesophageal Junction, And Oesophageal Adenocarcinoma (Checkmate 649): A Randomised, Open-Label, Phase 3 Trial Janjigian, Yelena Y; Shitara, Kohei; Moehler, Markus; Garrido, Marcelo; Salman, Pamela; Shen, Lin; Wyrwicz, Lucjan; Yamaguchi, Kensei; Skoczylas, Tomasz; Campos Bragagnoli, Arinilda; Liu, Tianshu; Schenker, Michael; Yanez, Patricio; Tehfe, Mustapha; Kowalyszyn, Ruben; Karamouzis, Michalis V; Bruges, Ricardo; Zander, Thomas; Pazo-Cid, Roberto; Hitre, Erika; Feeney, Kynan; Cleary, James M; Poulart, Valerie; Cullen, Dana; Lei, Ming; Xiao, Hong; Kondo, Kaoru; Li, Mingshun; Ajani, Jaffer A The Lancet 2021
10248 10.1016/s1470-2045(18)30111-6 Addition Of The Parp Inhibitor Veliparib Plus Carboplatin Or Carboplatin Alone To Standard Neoadjuvant Chemotherapy In Triple-Negative Breast Cancer (Brightness): A Randomised, Phase 3 Trial Loibl, Sibylle; O’Shaughnessy, Joyce; Untch, Michael; Sikov, William M; Rugo, Hope S; Mckee, Mark D; Huober, Jens; Golshan, Mehra; Von Minckwitz, Gunter; Maag, David; Sullivan, Danielle; Wolmark, Norman; Mcintyre, Kristi; Ponce Lorenzo, Jose J; Metzger Filho, Otto; Rastogi, Priya; Symmans, W Fraser; Liu, Xuan; Geyer, Charles E The Lancet Oncology 2018
10249 10.1016/s1470-2045(18)30119-0 Larotrectinib For Paediatric Solid Tumours Harbouring Ntrk Gene Fusions: Phase 1 Results From A Multicentre, Open-Label, Phase 1/2 Study Laetsch, Theodore W; Dubois, Steven G; Mascarenhas, Leo; Turpin, Brian; Federman, Noah; Albert, Catherine M; Nagasubramanian, Ramamoorthy; Davis, Jessica L; Rudzinski, Erin; Feraco, Angela M; Tuch, Brian B; Ebata, Kevin T; Reynolds, Mark; Smith, Steven; Cruickshank, Scott; Cox, Michael C; Pappo, Alberto S; Hawkins, Douglas S The Lancet Oncology 2018
10259 10.1016/s1470-2045(18)30481-9 Pertuzumab Plus Trastuzumab And Chemotherapy For Her2-Positive Metastatic Gastric Or Gastro-Oesophageal Junction Cancer (Jacob): Final Analysis Of A Double-Blind, Randomised, Placebo-Controlled Phase 3 Study Tabernero, Josep; Hoff, Paulo M; Shen, Lin; Ohtsu, Atsushi; Shah, Manish A; Cheng, Karen; Song, Chunyan; Wu, Haiyan; Eng-Wong, Jennifer; Kim, Katherine; Kang, Yoon-Koo The Lancet Oncology 2018
10262 10.1016/s1470-2045(18)30570-9 Neoadjuvant Chemotherapy With Or Without Anthracyclines In The Presence Of Dual Her2 Blockade For Her2-Positive Breast Cancer (Train-2): A Multicentre, Open-Label, Randomised, Phase 3 Trial Van Ramshorst, Mette S; Van Der Voort, Anna; Van Werkhoven, Erik D; Mandjes, Ingrid A; Kemper, Inge; Dezentje, Vincent O; Oving, Irma M; Honkoop, Aafke H; Tick, Lidwine W; Van De Wouw, Agnes J; Mandigers, Caroline M; Van Warmerdam, Laurence J; Wesseling, Jelle; Vrancken Peeters, Marie-Jeanne T; Linn, Sabine C; Sonke, Gabe S The Lancet Oncology 2018
10267 10.1016/s1470-2045(18)30649-1 Lorlatinib In Patients With Alk-Positive Non-Small-Cell Lung Cancer: Results From A Global Phase 2 Study Solomon, Benjamin J; Besse, Benjamin; Bauer, Todd M; Felip, Enriqueta; Soo, Ross A; Camidge, D Ross; Chiari, Rita; Bearz, Alessandra; Lin, Chia-Chi; Gadgeel, Shirish M; Riely, Gregory J; Tan, Eng Huat; Seto, Takashi; James, Leonard P; Clancy, Jill S; Abbattista, Antonello; Martini, Jean-Francois; Chen, Joseph; Peltz, Gerson; Thurm, Holger; Ou, Sai-Hong Ignatius; Shaw, Alice T The Lancet Oncology 2018
10270 10.1016/s1470-2045(18)30739-3 Trifluridine/Tipiracil Versus Placebo In Patients With Heavily Pretreated Metastatic Gastric Cancer (Tags): A Randomised, Double-Blind, Placebo-Controlled, Phase 3 Trial Shitara, Kohei; Doi, Toshihiko; Dvorkin, Mikhail; Mansoor, Wasat; Arkenau, Hendrik-Tobias; Prokharau, Aliaksandr; Alsina, Maria; Ghidini, Michele; Faustino, Catia; Gorbunova, Vera; Zhavrid, Edvard; Nishikawa, Kazuhiro; Hosokawa, Ayumu; Yalc<U+0131>n, <U+015E>uayib; Fujitani, Kazumasa; Beretta, Giordano D; Cutsem, Eric Van; Winkler, Robert E; Makris, Lukas; Ilson, David H; Tabernero, Josep The Lancet Oncology 2018
10274 10.1016/s1470-2045(18)30812-x Pembrolizumab Plus Trastuzumab In Trastuzumab-Resistant, Advanced, Her2-Positive Breast Cancer (Panacea): A Single-Arm, Multicentre, Phase 1B<U+2013>2 Trial Loi, Sherene; Giobbie-Hurder, Anita; Gombos, Andrea; Bachelot, Thomas; Hui, Rina; Curigliano, Giuseppe; Campone, Mario; Biganzoli, Laura; Bonnefoi, Herve; Jerusalem, Guy; Bartsch, Rupert; Rabaglio-Poretti, Manuela; Kammler, Roswitha; Maibach, Rudolf; Smyth, Mark J; Di Leo, Angelo; Colleoni, Marco; Viale, Giuseppe; Regan, Meredith M; Andre, Fabrice; Fumagalli, Debora; Gelber, Richard D; Goulioti, Theodora; Hiltbrunner, Anita; Hui, Rita; Roschitzki, Heidi; Ruepp, Barbara; Boyle, Fran; Stahel, Rolf; Aebi, Stefan; Coates, Alan S; Goldhirsch, Aron; Karlsson, Per; Kossler, Ingrid; Fournarakou, Stamatina; Gasca, Adriana; Pfister, Rita; Ribeli-Hofmann, Sabrina; Weber, Magdelena; Celotto, Daniela; Comune, Carmen; Frapolli, Michela; Sanchez-Hohl, Magdalena; Huang, Hui; Mahoney, Caitlin; Price, Karen; Scott, Karolyn; Shaw, Holly; Fischer, Susan; Greco, Monica; King, Colleen; Andrighetto, Stefania; Piccart-Gebhart, Martine; Findlay, Heather; Jenkins, Michelle; Karantza, Vassiliki; Mejia, Jaime; Schneier, Patrick The Lancet Oncology 2019
10276 10.1016/s1470-2045(18)30905-7 Konstantinopoulos, Panagiotis A; Barry, William T; Birrer, Michael; Westin, Shannon N; Cadoo, Karen A; Shapiro, Geoffrey I; Mayer, Erica L; O’Cearbhaill, Roisin E; Coleman, Robert L; Kochupurakkal, Bose; Whalen, Christin; Curtis, Jennifer; Farooq, Sarah; Luo, Weixiu; Eismann, Julia; Buss, Mary K; Aghajanian, Carol; Mills, Gordon B; Palakurthi, Sangeetha; Kirschmeier, Paul; Liu, Joyce; Cantley, Lewis C; Kaufmann, Scott H; Swisher, Elizabeth M; D’Andrea, Alan D; Winer, Eric; Wulf, Gerburg M; Matulonis, Ursula A The Lancet Oncology 2019
10280 10.1016/s1470-2045(19)30029-4 Niraparib Monotherapy For Late-Line Treatment Of Ovarian Cancer (Quadra): A Multicentre, Open-Label, Single-Arm, Phase 2 Trial Moore, Kathleen N; Secord, Angeles Alvarez; Geller, Melissa A; Miller, David Scott; Cloven, Noelle; Fleming, Gini F; Wahner Hendrickson, Andrea E; Azodi, Masoud; Disilvestro, Paul; Oza, Amit M; Cristea, Mihaela; Berek, Jonathan S; Chan, John K; Rimel, Bobbie J; Matei, Daniela E; Li, Yong; Sun, Kaiming; Luptakova, Katarina; Matulonis, Ursula A; Monk, Bradley J The Lancet Oncology 2019
10281 10.1016/s1470-2045(19)30035-x Erlotinib Plus Bevacizumab Versus Erlotinib Alone In Patients With Egfr-Positive Advanced Non-Squamous Non-Small-Cell Lung Cancer (Nej026): Interim Analysis Of An Open-Label, Randomised, Multicentre, Phase 3 Trial Saito, Haruhiro; Fukuhara, Tatsuro; Furuya, Naoki; Watanabe, Kana; Sugawara, Shunichi; Iwasawa, Shunichiro; Tsunezuka, Yoshio; Yamaguchi, Ou; Okada, Morihito; Yoshimori, Kozo; Nakachi, Ichiro; Gemma, Akihiko; Azuma, Koichi; Kurimoto, Futoshi; Tsubata, Yukari; Fujita, Yuka; Nagashima, Hiromi; Asai, Gyo; Watanabe, Satoshi; Miyazaki, Masaki; Hagiwara, Koichi; Nukiwa, Toshihiro; Morita, Satoshi; Kobayashi, Kunihiko; Maemondo, Makoto The Lancet Oncology 2019
10283 10.1016/s1470-2045(19)30088-9 Trastuzumab Deruxtecan (Ds-8201A) In Patients With Advanced Her2-Positive Gastric Cancer: A Dose-Expansion, Phase 1 Study Shitara, Kohei; Iwata, Hiroji; Takahashi, Shunji; Tamura, Kenji; Park, Haeseong; Modi, Shanu; Tsurutani, Junji; Kadowaki, Shigenori; Yamaguchi, Kensei; Iwasa, Satoru; Saito, Kaku; Fujisaki, Yoshihiko; Sugihara, Masahiro; Shahidi, Javad; Doi, Toshihiko The Lancet Oncology 2019
10285 10.1016/s1470-2045(19)30097-x Trastuzumab Deruxtecan (Ds-8201A) In Patients With Advanced Her2-Positive Breast Cancer Previously Treated With Trastuzumab Emtansine: A Dose-Expansion, Phase 1 Study Tamura, Kenji; Tsurutani, Junji; Takahashi, Shunji; Iwata, Hiroji; Krop, Ian E; Redfern, Charles; Sagara, Yasuaki; Doi, Toshihiko; Park, Haeseong; Murthy, Rashmi K; Redman, Rebecca A; Jikoh, Takahiro; Lee, Caleb; Sugihara, Masahiro; Shahidi, Javad; Yver, Antoine; Modi, Shanu The Lancet Oncology 2019
10291 10.1016/s1470-2045(19)30328-6 Trastuzumab Duocarmazine In Locally Advanced And Metastatic Solid Tumours And Her2-Expressing Breast Cancer: A Phase 1 Dose-Escalation And Dose-Expansion Study Banerji, Udai; Van Herpen, Carla M L; Saura, Cristina; Thistlethwaite, Fiona; Lord, Simon; Moreno, Victor; Macpherson, Iain R; Boni, Valentina; Rolfo, Christian; De Vries, Elisabeth G E; Rottey, Sylvie; Geenen, Jill; Eskens, Ferry; Gil-Martin, Marta; Mommers, Ellen C; Koper, Norbert P; Aftimos, Philippe The Lancet Oncology 2019
10302 10.1016/s1470-2045(19)30515-7 Niraparib Plus Bevacizumab Versus Niraparib Alone For Platinum-Sensitive Recurrent Ovarian Cancer (Nsgo-Avanova2/Engot-Ov24): A Randomised, Phase 2, Superiority Trial Mirza, Mansoor Raza; Avall Lundqvist, Elisabeth; Birrer, Michael J; Depont Christensen, Rene; Nyvang, Gitte-Bettina; Malander, Susanne; Anttila, Maarit; Werner, Theresa L; Lund, Bente; Lindahl, Gabriel; Hietanen, Sakari; Peen, Ulla; Dimoula, Maria; Roed, Henrik; Or Knudsen, Anja; Staff, Synnove; Krog Vistisen, Anders; Bjorge, Line; Maenpaa, Johanna U The Lancet Oncology 2019
10303 10.1016/s1470-2045(19)30626-6 Nivolumab Versus Chemotherapy In Patients With Advanced Oesophageal Squamous Cell Carcinoma Refractory Or Intolerant To Previous Chemotherapy (Attraction-3): A Multicentre, Randomised, Open-Label, Phase 3 Trial Kato, Ken; Cho, Byoung Chul; Takahashi, Masanobu; Okada, Morihito; Lin, Chen-Yuan; Chin, Keisho; Kadowaki, Shigenori; Ahn, Myung-Ju; Hamamoto, Yasuo; Doki, Yuichiro; Yen, Chueh-Chuan; Kubota, Yutaro; Kim, Sung-Bae; Hsu, Chih-Hung; Holtved, Eva; Xynos, Ioannis; Kodani, Mamoru; Kitagawa, Yuko The Lancet Oncology 2019
10304 10.1016/s1470-2045(19)30634-5 Ramucirumab Plus Erlotinib In Patients With Untreated, Egfr-Mutated, Advanced Non-Small-Cell Lung Cancer (Relay): A Randomised, Double-Blind, Placebo-Controlled, Phase 3 Trial Nakagawa, Kazuhiko; Garon, Edward B; Seto, Takashi; Nishio, Makoto; Ponce Aix, Santiago; Paz-Ares, Luis; Chiu, Chao-Hua; Park, Keunchil; Novello, Silvia; Nadal, Ernest; Imamura, Fumio; Yoh, Kiyotaka; Shih, Jin-Yuan; Au, Kwok Hung; Moro-Sibilot, Denis; Enatsu, Sotaro; Zimmermann, Annamaria; Frimodt-Moller, Bente; Visseren-Grul, Carla; Reck, Martin; Chu, Quincy; Cortot, Alexis; Pujol, Jean-Louis; Moro-Sibilot, Denis; Fabre, Elizabeth; Lamour, Corinne; Bischoff, Helge; Kollmeier, Jens; Reck, Martin; Kimmich, Martin; Engel-Riedel, Walburga; Hammerschmidt, Stefan; Schutte, Wolfgang; Syrigos, Konstantinos; Ho, James Chung Man; Au, Kwok-Hung; Novello, Silvia; Ardizzoni, Andrea; Pasello, Giulia; Gregorc, Vanessa; Del Conte, Alessandro; Galetta, Domenico; Takahashi, Toshiaki; Nakagawa, Kazuhiko; Nishio, Makoto; Yoh, Kiyotaka; Seto, Takashi; Imamura, Fumio; Kumagai, Toru; Hotta, Katsuyuki; Goto, Yasushi; Hosomi, Yukio; Sakai, Hiroshi; Takiguchi, Yuichi; Kim, Young Hak; Kurata, Takayasu; Yamaguchi, Hiroyuki; Daga, Haruko; Okamoto, Isamu; Satouchi, Miyako; Ikeda, Satoshi; Kasahara, Kazuo; Atagi, Shinji; Azuma, Koichi; Kumagai, Toru; Aoe, Keisuke; Kumagai, Toru; Aoe, Keisuke; Horio, Yoshitsugu; Yamamoto, Nobuyuki; Tanaka, Hiroshi; Watanabe, Satoshi; Nogami, Naoyuki; Ozaki, Tomohiro; Koyama, Ryo; Hirashima, Tomonori; Kaneda, Hiroyasu; Tomii, Keisuke; Fujita, Yuka; Seike, Masahiro; Nishimura, Naoki; Kato, Terufumi; Ichiki, Masao; Saka, Hideo; Hirano, Katsuya; Nakahara, Yasuharu; Sugawara, Shunichi; Park, Keunchil; Kim, Sang-We; Min, Young Joo; Lee, Hyun Woo; Kang, Jin-Hyoung; An, Ho Jung; Lee, Ki Hyeong; Kim, Jin-Soo; Lee, Gyeong-Won; Lee, Sung Yong; Alexandru, Aurelia; Udrea, Anghel Adrian; Juan-Vidal, Oscar; Nadal-Alforja, Ernest; Gil-Bazo, Ignacio; Ponce-Aix, Santiago; Paz-Ares, Luis; Rubio-Viqueira, Belen; Alonso Garcia, Miriam; Felip Font, Enriqueta; Fuentes Pradera, Jose; Coves Sarto, Juan; Lin, Meng-Chih; Su, Wu-Chou; Hsia, Te-Chun; Chang, Gee-Chen; Wei, Yu-Feng; Chiu, Chao-Hua; Shih, Jin-Yuan; Su, Jian; Cicin, Irfan; Goksel, Tuncay; Harputluoglu, Hakan; Ozyilkan, Ozgur; Henning, Ivo; Popat, Sanjay; Hatcher, Olivia; Mileham, Kathryn; Acoba, Jared; Garon, Edward; Jung, Gabriel; Raj, Moses; Martin, William; Dakhil, Shaker The Lancet Oncology 2019
10306 10.1016/s1470-2045(19)30655-2 Lorlatinib In Advanced Ros1-Positive Non-Small-Cell Lung Cancer: A Multicentre, Open-Label, Single-Arm, Phase 1<U+2013>2 Trial Shaw, Alice T; Solomon, Benjamin J; Chiari, Rita; Riely, Gregory J; Besse, Benjamin; Soo, Ross A; Kao, Steven; Lin, Chia-Chi; Bauer, Todd M; Clancy, Jill S; Thurm, Holger; Martini, Jean-Francois; Peltz, Gerson; Abbattista, Antonello; Li, Sherry; Ou, Sai-Hong Ignatius The Lancet Oncology 2019
10309 10.1016/s1470-2045(19)30689-8 Atezolizumab Plus Nab-Paclitaxel As First-Line Treatment For Unresectable, Locally Advanced Or Metastatic Triple-Negative Breast Cancer (Impassion130): Updated Efficacy Results From A Randomised, Double-Blind, Placebo-Controlled, Phase 3 Trial Schmid, Peter; Rugo, Hope S; Adams, Sylvia; Schneeweiss, Andreas; Barrios, Carlos H; Iwata, Hiroji; Dieras, Veronique; Henschel, Volkmar; Molinero, Luciana; Chui, Stephen Y; Maiya, Vidya; Husain, Amreen; Winer, Eric P; Loi, Sherene; Emens, Leisha A The Lancet Oncology 2020
10310 10.1016/s1470-2045(19)30690-4 Entrectinib In Ros1 Fusion-Positive Non-Small-Cell Lung Cancer: Integrated Analysis Of Three Phase 1<U+2013>2 Trials Drilon, Alexander; Siena, Salvatore; Dziadziuszko, Rafal; Barlesi, Fabrice; Krebs, Matthew G; Shaw, Alice T; De Braud, Filippo; Rolfo, Christian; Ahn, Myung-Ju; Wolf, Jurgen; Seto, Takashi; Cho, Byoung Chul; Patel, Manish R; Chiu, Chao-Hua; John, Thomas; Goto, Koichi; Karapetis, Christos S; Arkenau, Hendrick-Tobias; Kim, Sang-We; Ohe, Yuichiro; Li, Yu-Chung; Chae, Young K; Chung, Christine H; Otterson, Gregory A; Murakami, Haruyasu; Lin, Chia-Chi; Tan, Daniel S W; Prenen, Hans; Riehl, Todd; Chow-Maneval, Edna; Simmons, Brian; Cui, Na; Johnson, Ann; Eng, Susan; Wilson, Timothy R; Doebele, Robert C The Lancet Oncology 2020
10311 10.1016/s1470-2045(19)30691-6 Entrectinib In Patients With Advanced Or Metastatic Ntrk Fusion-Positive Solid Tumours: Integrated Analysis Of Three Phase 1<U+2013>2 Trials Doebele, Robert C; Drilon, Alexander; Paz-Ares, Luis; Siena, Salvatore; Shaw, Alice T; Farago, Anna F; Blakely, Collin M; Seto, Takashi; Cho, Byung Chul; Tosi, Diego; Besse, Benjamin; Chawla, Sant P; Bazhenova, Lyudmila; Krauss, John C; Chae, Young Kwang; Barve, Minal; Garrido-Laguna, Ignacio; Liu, Stephen V; Conkling, Paul; John, Thomas; Fakih, Marwan; Sigal, Darren; Loong, Herbert H; Buchschacher, Gary L; Garrido, Pilar; Nieva, Jorge; Steuer, Conor; Overbeck, Tobias R; Bowles, Daniel W; Fox, Elizabeth; Riehl, Todd; Chow-Maneval, Edna; Simmons, Brian; Cui, Na; Johnson, Ann; Eng, Susan; Wilson, Timothy R; Demetri, George D The Lancet Oncology 2020
10316 10.1016/s1470-2045(19)30785-5 Osimertinib Plus Savolitinib In Patients With Egfr Mutation-Positive, Met-Amplified, Non-Small-Cell Lung Cancer After Progression On Egfr Tyrosine Kinase Inhibitors: Interim Results From A Multicentre, Open-Label, Phase 1B Study Sequist, Lecia V; Han, Ji-Youn; Ahn, Myung-Ju; Cho, Byoung Chul; Yu, Helena; Kim, Sang-We; Yang, James Chih-Hsin; Lee, Jong Seok; Su, Wu-Chou; Kowalski, Dariusz; Orlov, Sergey; Cantarini, Mireille; Verheijen, Remy B; Mellemgaard, Anders; Ottesen, Lone; Frewer, Paul; Ou, Xiaoling; Oxnard, Geoffrey The Lancet Oncology 2020
10320 10.1016/s1470-2045(19)30856-3 Larotrectinib In Patients With Trk Fusion-Positive Solid Tumours: A Pooled Analysis Of Three Phase 1/2 Clinical Trials Hong, David S; Dubois, Steven G; Kummar, Shivaani; Farago, Anna F; Albert, Catherine M; Rohrberg, Kristoffer S; Van Tilburg, Cornelis M; Nagasubramanian, Ramamoorthy; Berlin, Jordan D; Federman, Noah; Mascarenhas, Leo; Geoerger, Birgit; Dowlati, Afshin; Pappo, Alberto S; Bielack, Stefan; Doz, Francois; Mcdermott, Ray; Patel, Jyoti D; Schilder, Russell J; Tahara, Makoto; Pfister, Stefan M; Witt, Olaf; Ladanyi, Marc; Rudzinski, Erin R; Nanda, Shivani; Childs, Barrett H; Laetsch, Theodore W; Hyman, David M; Drilon, Alexander The Lancet Oncology 2020
10321 10.1016/s1470-2045(19)30863-0 Pertuzumab, Trastuzumab, And Docetaxel For Her2-Positive Metastatic Breast Cancer (Cleopatra): End-Of-Study Results From A Double-Blind, Randomised, Placebo-Controlled, Phase 3 Study Swain, Sandra M; Miles, David; Kim, Sung-Bae; Im, Young-Hyuck; Im, Seock-Ah; Semiglazov, Vladimir; Ciruelos, Eva; Schneeweiss, Andreas; Loi, Sherene; Monturus, Estefania; Clark, Emma; Knott, Adam; Restuccia, Eleonora; Benyunes, Mark C; Cortes, Javier; Agajanian, Richy; Ahmad, Rizvana; Aktas, Bahriye; Alencar, Victor Hugo; Amadori, Dino; Andrade, Jurandyr; Andre Franke, Fabio; Angiolini, Catia; Aogi, Kenjiro; Armor, Jess; Arpornwirat, Wichit; Assersohn, Laura; Audeh, William; Aulitzky, Walter; Azevedo, Sergio; Bartoli, Maria Alejandra; Batista Lopez, Norberto; Bianconi, Maria; Biganzoli, Laura; Birhiray, Ruemu; Bitina, Marianna; Blachy, Ron; Blackwell, Kimberly; Blanchard, Rita; Blanchet, Paulette; Boiangiu, Ion; Bower, Barbara; Brezden-Masley, Christine; Brufsky, Adam; Budde, Leanne; Caguioa, Priscilla; Calvo, Lourdes; Campone, Mario; Carroll, Robert R.; Castro, Hugo; Chan, Valorie; Charu, Veena; Cinieri, Saverio; Clemens, Michael; Conejo, Emilio Alba; Cortes, Eduardo; Coudert, Bruno; Cronemberger, Eduardo; Cubero, Daniel; Dakhil, Shaker; Daniel, Brooke; Davidson, Neville; De Fatima Gaui, Maria; De La Cruz, Susana; Del Pilar, Maria; Delgado, Gilson; Ellerton, John A.; Estuardo, Cesar; Fehrenbacher, Louis; Ferrero, Jean-Marc; Flynn, Patrick J.; Foszczynska-Kloda, Malgorzata; Franco, Sandra; Fujii, Hirofumi; Gallagher, Chris; Gamucci, Teresa; Giacomi, Nora; Gil I Gil, Miguel; Gonzalez Martin, Antonio; Gorbunova, Vera; Gotovkin, Eugeny; Green, Nathan; Grincuka, Elza; Grischke, Eva-Maria; Hansen, Vincent; Hargis, Jeffrey; Hauschild, Maik; Hegg, Roberto; Hendricks, Carolyn; Hermann, Robert; Hoff, Paulo; Horiguchi, Jun; Hornedo Muguiro, Javier; Iacobelli, Stefano; Inoue, Kenichi; Ismael, Gustavo; Itoh, Yoshinori; Iwata, Dr Hiroji; Jendiroba, Davi; Jochim, Rosa; Jones, Alison; Just, Marianne; Kallab, Andre; Karwal, Mark; Kashiwaba, Masahiro; Kato, Giraldo; Kaufman, Peter A.; Kellokumpu-Lehtinen, Pirkko; Kirsch, Andreas; Kiselev, Igor; Klein, Paula; Kohno, Norio; Kopp, Mikhail; Kostovska-Maneva, Liljana; Kotliar, Mauricio; Kudaba, Iveta; Kummel, Sherko; Kuroi, Katsumasa; Lacava, Juan; Latini, Luciano; Lee, Soo Chin; Lichinitser, Mikhail; Lobo, Christopher; Maintz, Christoph; Maneecahvakajorn, Jedzada; Marme, Alexander; Martinez, Gloria; Masuda, Norikazu; Matwiejuk, Mario; Merculov, Vladimir; Michaelson, Richard; Miguel, Luis; Monroy, Hernandez; Montemurro, Filippo; Morales, Serafin; Moura, Rodrigo; Mueller, Volkmar; Mulatero, Clive; Nakagami, Kazuhiko; Nakayama, Takahiro; Neidhart, Jeff; Nguyen, An; Nishimura, Reiki; Ogata, Haruki; O’Reilly, Susan; O’Rourke, Timothy; Otero Reye, Douglas; Ouyang, Xuenong; Patel, Ravi; Patel, Taral; Pedrini, Jose Luiz; Pereira, Rodrigo; Perez, Alejandra; Peterson, Carol; Pienkowski, Tadeusz; Pinczowski, Helio; Polikoff, Jonathan; Polkowski, Wojciech; Price, Paola Edith; Prill, Sue; Priou, Frank; Purkalne, Gunta; Pyrhoenen, Seppo; Quackenbush, Robert; Rai, Yoshiaki; Ribelles, Nuria; Ro, Jungsil; Robinson, Anne; Robles, Robert; Rodriguez, Gladys; Roman, Laslo; Saji, Shigehira; Sanchez-Rovira, Pedro; Sato, Nobuaki; Schmidt, Marcus; Schumacher, Claudia; Senecal, Frank; Sharma, Priyanka; Shen, Zhenzhou; Shirinkin, Vadim; Simoncini, Edda; Sirisinha, Thitiya; Smith, Raymond; Sohn, Joo-Hyuk; Soldic, Zeljko; Soria, Tania; Spicer, Darcy; Srimuninnimit, Vichien; Sriuranpong, Virote; Staroslawska, Elzbieta; Stefanovski, Petar; Sunpaweravong, Patrapim; Taguchi, Julie; Takeda, Koji; Tellez-Trevilla, Gabriel; Thomas, Randall; Thomssen, Christoph; Toache, Zetina; Tokuda, Yutaka; Tomczak, Piotr; Tosello, Celia; Tsugawa, Koichiro; Tudtud, Dennis; Ueno, Takayuki; Van Eyll, Brigitte; Varela, Mirta; Vasev, Nikola; Vrbanec, Damir; Wang, Xiaojia; Wang, Liwei; Watanabe, Junichiro; Waterhouse, David; Wesenberg, Birgitta; Wheatley, Duncan; Wong, Zee Wan; Yadav, Sanjay; Yadav, Sanjay; Yardley, Denise; Yau, Tsz-Kok; Yeo, Winnie; Ying, Cheng; Youn Oh, Do The Lancet Oncology 2020
10327 10.1016/s1470-2045(20)30110-8 Camrelizumab Versus Investigator’S Choice Of Chemotherapy As Second-Line Therapy For Advanced Or Metastatic Oesophageal Squamous Cell Carcinoma (Escort): A Multicentre, Randomised, Open-Label, Phase 3 Study Huang, Jing; Xu, Jianming; Chen, Yun; Zhuang, Wu; Zhang, Yiping; Chen, Zhendong; Chen, Jia; Zhang, Helong; Niu, Zuoxing; Fan, Qingxia; Lin, Lizhu; Gu, Kangsheng; Liu, Ying; Ba, Yi; Miao, Zhanhui; Jiang, Xiaodong; Zeng, Ming; Chen, Jianhua; Fu, Zhichao; Gan, Lu; Wang, Jun; Zhan, Xianbao; Liu, Tianshu; Li, Zhiping; Shen, Lin; Shu, Yongqian; Zhang, Tao; Yang, Qing; Zou, Jianjun; Luo, Suxia; Peng, Feng; Wu, Gang; Xu, Nong; Zhao, Lin; Ma, Dong; Qin, Shukui; Ren, Wei; Li, Enxiao; Lu, Hongda; Pan, Yueyin; Xiong, Jianping; Yuan, Ying; Bai, Yuxian; Chen, Lei; Hu, Yi; Zhang, Li; Gao, Yong The Lancet Oncology 2020
10328 10.1016/s1470-2045(20)30112-1 Abemaciclib Plus Trastuzumab With Or Without Fulvestrant Versus Trastuzumab Plus Standard-Of-Care Chemotherapy In Women With Hormone Receptor-Positive, Her2-Positive Advanced Breast Cancer (Monarcher): A Randomised, Open-Label, Phase 2 Trial Tolaney, Sara M; Wardley, Andrew M; Zambelli, Stefania; Hilton, John F; Troso-Sandoval, Tiffany A; Ricci, Francesco; Im, Seock-Ah; Kim, Sung-Bae; Johnston, Stephen Rd; Chan, Arlene; Goel, Shom; Catron, Kristen; Chapman, Sonya C; Price, Gregory L; Yang, Zhengyu; Gainford, M Corona; Andre, Fabrice The Lancet Oncology 2020
10333 10.1016/s1470-2045(20)30169-8 First-Line Pembrolizumab And Trastuzumab In Her2-Positive Oesophageal, Gastric, Or Gastro-Oesophageal Junction Cancer: An Open-Label, Single-Arm, Phase 2 Trial Janjigian, Yelena Y; Maron, Steven B; Chatila, Walid K; Millang, Brittanie; Chavan, Shweta S; Alterman, Carly; Chou, Joanne F; Segal, Michal F; Simmons, Marc Z; Momtaz, Parisa; Shcherba, Marina; Ku, Geoffrey Y; Zervoudakis, Alice; Won, Elizabeth S; Kelsen, David P; Ilson, David H; Nagy, Rebecca J; Lanman, Richard B; Ptashkin, Ryan N; Donoghue, Mark T A; Capanu, Marinela; Taylor, Barry S; Solit, David B; Schultz, Nikolaus; Hechtman, Jaclyn F The Lancet Oncology 2020
10339 10.1016/s1470-2045(20)30324-7 Olaparib And Durvalumab In Patients With Germline Brca-Mutated Metastatic Breast Cancer (Mediola): An Open-Label, Multicentre, Phase 1/2, Basket Study Domchek, Susan M; Postel-Vinay, Sophie; Im, Seock-Ah; Park, Yeon Hee; Delord, Jean-Pierre; Italiano, Antoine; Alexandre, Jerome; You, Benoit; Bastian, Sara; Krebs, Matthew G; Wang, Ding; Waqar, Saiama N; Lanasa, Mark; Rhee, Joon; Gao, Haiyan; Rocher-Ros, Vidalba; Jones, Emma V; Gulati, Sakshi; Coenen-Stass, Anna; Kozarewa, Iwanka; Lai, Zhongwu; Angell, Helen K; Opincar, Laura; Herbolsheimer, Pia; Kaufman, Bella The Lancet Oncology 2020
10345 10.1016/s1470-2045(20)30447-2 Veliparib With Carboplatin And Paclitaxel In Brca-Mutated Advanced Breast Cancer (Brocade3): A Randomised, Double-Blind, Placebo-Controlled, Phase 3 Trial Dieras, Veronique; Han, Hyo S; Kaufman, Bella; Wildiers, Hans; Friedlander, Michael; Ayoub, Jean-Pierre; Puhalla, Shannon L; Bondarenko, Igor; Campone, Mario; Jakobsen, Erik H; Jalving, Mathilde; Oprean, Cristina; Palacova, Marketa; Park, Yeon Hee; Shparyk, Yaroslav; Yanez, Eduardo; Khandelwal, Nikhil; Kundu, Madan G; Dudley, Matthew; Ratajczak, Christine K; Maag, David; Arun, Banu K The Lancet Oncology 2020
10439 10.1016/s2213-2600(19)30053-0 Alectinib Versus Crizotinib In Untreated Asian Patients With Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer (Alesia): A Randomised Phase 3 Study Zhou, Caicun; Kim, Sang-We; Reungwetwattana, Thanyanan; Zhou, Jianying; Zhang, Yiping; He, Jianxing; Yang, Jin-Ji; Cheng, Ying; Lee, Se-Hoon; Bu, Lilian; Xu, Tingting; Yang, Li; Wang, Chao; Liu, Ting; Morcos, Peter N; Lu, You; Zhang, Li The Lancet Respiratory Medicine 2019
12642 10.1038/s41379-018-0118-3 Molecular Characterization Of Cancers With Ntrk Gene Fusions Gatalica, Zoran; Xiu, Joanne; Swensen, Jeffrey; Vranic, Semir, 0000-0001-9743-7265 Modern Pathology 2018
12644 10.1038/s41379-019-0324-7 Ntrk Fusion Detection Across Multiple Assays And 33,997 Cases: Diagnostic Implications And Pitfalls Solomon, James P.; Linkov, Irina; Rosado, Andrea; Mullaney, Kerry; Rosen, Ezra Y.; Frosina, Denise; Jungbluth, Achim A.; Zehir, Ahmet, 0000-0001-5406-4104; Benayed, Ryma; Drilon, Alexander, 0000-0001-6806-9061; Hyman, David M., 0000-0001-8150-9762; Ladanyi, Marc; Sireci, Anthony N.; Hechtman, Jaclyn F. Modern Pathology 2019
12683 10.1038/s41416-018-0274-8 Candidate Biomarkers Of Parp Inhibitor Sensitivity In Ovarian Cancer Beyond The Brca Genes British Journal Of Cancer 2018
12686 10.1038/s41416-019-0573-8 Resistance Mechanisms To Osimertinib In Egfr-Mutated Non-Small Cell Lung Cancer Leonetti, Alessandro; Sharma, Sugandhi; Minari, Roberta; Perego, Paola; Giovannetti, Elisa; Tiseo, Marcello, 0000-0002-9204-1728 British Journal Of Cancer 2019
12787 10.1038/s41467-018-05564-z Methylation Of All Brca1 Copies Predicts Response To The Parp Inhibitor Rucaparib In Ovarian Carcinoma Kondrashova, Olga, 0000-0003-0022-5149; Topp, Monique; Nesic, Ksenija; Lieschke, Elizabeth; Ho, Gwo-Yaw; Harrell, Maria I.; Zapparoli, Giada V.; Hadley, Alison; Holian, Robert; Boehm, Emma; Heong, Valerie; Sanij, Elaine; Pearson, Richard B., 0000-0001-5919-5090; Krais, John J.; Johnson, Neil; Mcnally, Orla; Ananda, Sumitra; Alsop, Kathryn; Hutt, Karla J.; Kaufmann, Scott H., 0000-0002-4900-7145; Lin, Kevin K.; Harding, Thomas C.; Traficante, Nadia; Defazio, Anna; Mcneish, Iain A., 0000-0002-9387-7586; Bowtell, David D.; Swisher, Elizabeth M.; Dobrovic, Alexander; Wakefield, Matthew J., 0000-0001-6624-4698; Scott, Clare L., 0000-0002-3689-5956 Nature Communications 2018
13106 10.1038/s41467-019-11048-5 Brca2 Abrogation Triggers Innate Immune Responses Potentiated By Treatment With Parp Inhibitors Reislander, Timo, 0000-0003-0981-8311; Lombardi, Emilia Puig; Groelly, Florian J.; Miar, Ana; Porru, Manuela; Di Vito, Serena; Wright, Benjamin; Lockstone, Helen; Biroccio, Annamaria; Harris, Adrian, 0000-0003-1376-8409; Londono-Vallejo, Arturo, 0000-0003-3535-7563; Tarsounas, Madalena Nature Communications 2019
13126 10.1038/s41467-019-11496-z The New-Generation Selective Ros1/Ntrk Inhibitor Ds-6051B Overcomes Crizotinib Resistant Ros1-G2032R Mutation In Preclinical Models Katayama, Ryohei, 0000-0001-7394-895X; Gong, Bo; Togashi, Noriko, 0000-0003-2606-0231; Miyamoto, Masaya; Kiga, Masaki; Iwasaki, Shiho; Kamai, Yasuki; Tominaga, Yuichi; Takeda, Yasuyuki; Kagoshima, Yoshiko; Shimizu, Yuki; Seto, Yosuke; Oh-Hara, Tomoko; Koike, Sumie; Nakao, Naoki; Hanzawa, Hiroyuki; Watanabe, Kengo, 0000-0001-7808-1160; Yoda, Satoshi, 0000-0003-4201-1392; Yanagitani, Noriko; Hata, Aaron N.; Shaw, Alice T.; Nishio, Makoto; Fujita, Naoya; Isoyama, Takeshi, 0000-0002-2894-5773 Nature Communications 2019
13282 10.1038/s41467-020-15315-8 Immunogenomic Profiling Determines Responses To Combined Parp And Pd-1 Inhibition In Ovarian Cancer Nature Communications 2020
13938 10.1038/s41571-018-0113-0 Ntrk Fusion-Positive Cancers And Trk Inhibitor Therapy Cocco, Emiliano; Scaltriti, Maurizio; Drilon, Alexander, 0000-0001-6806-9061 Nature Reviews Clinical Oncology 2018
14637 10.1038/s41591-018-0009-7 Carboplatin In Brca1/2-Mutated And Triple-Negative Breast Cancer Brcaness Subgroups: The Tnt Trial Tutt, Andrew, 0000-0001-8715-2901; Tovey, Holly; Cheang, Maggie Chon U.; Kernaghan, Sarah; Kilburn, Lucy; Gazinska, Patrycja; Owen, Julie; Abraham, Jacinta; Barrett, Sophie; Barrett-Lee, Peter; Brown, Robert; Chan, Stephen; Dowsett, Mitchell; Flanagan, James M; Fox, Lisa; Grigoriadis, Anita, 0000-0003-3434-201X; Gutin, Alexander; Harper-Wynne, Catherine; Hatton, Matthew Q.; Hoadley, Katherine A.; Parikh, Jyoti; Parker, Peter; Perou, Charles M.; Roylance, Rebecca; Shah, Vandna; Shaw, Adam; Smith, Ian E.; Timms, Kirsten M.; Wardley, Andrew M., 0000-0002-9639-0888; Wilson, Gregory; Gillett, Cheryl; Lanchbury, Jerry S.; Ashworth, Alan; Rahman, Nazneen; Harries, Mark; Ellis, Paul; Pinder, Sarah E., 0000-0003-4167-8910; Bliss, Judith M. Nature Medicine 2018
14649 10.1038/s41591-018-0101-z Comprehensive Molecular Characterization Of Clinical Responses To Pd-1 Inhibition In Metastatic Gastric Cancer Kim, Seung Tae; Cristescu, Razvan, 0000-0002-9978-0339; Bass, Adam J.; Kim, Kyoung-Mee, 0000-0002-1162-9205; Odegaard, Justin I.; Kim, Kyung, 0000-0002-7712-3135; Liu, Xiao Qiao, 0000-0002-6371-6503; Sher, Xinwei, 0000-0003-3977-3695; Jung, Hun; Lee, Mijin; Lee, Sujin; Park, Se Hoon; Park, Joon Oh; Park, Young Suk; Lim, Ho Yeong; Lee, Hyuk; Choi, Mingew; Talasaz, Amirali; Kang, Peter Soonmo; Cheng, Jonathan; Loboda, Andrey, 0000-0003-4239-184X; Lee, Jeeyun, 0000-0002-4911-6165; Kang, Won Ki Nature Medicine 2018
14681 10.1038/s41591-019-0432-4 Immune Induction Strategies In Metastatic Triple-Negative Breast Cancer To Enhance The Sensitivity To Pd-1 Blockade: The Tonic Trial Voorwerk, Leonie; Slagter, Maarten; Horlings, Hugo M., 0000-0003-4782-8828; Sikorska, Karolina; Van De Vijver, Koen K., 0000-0002-2026-9790; De Maaker, Michiel; Nederlof, Iris; Kluin, Roelof J. C.; Warren, Sarah; Ong, Sufey; Wiersma, Terry G.; Russell, Nicola S., 0000-0003-3507-9620; Lalezari, Ferry; Schouten, Philip C.; Bakker, Noor A. M.; Ketelaars, Steven L. C.; Peters, Dennis; Lange, Charlotte A. H.; Van Werkhoven, Erik, 0000-0001-7469-7427; Van Tinteren, Harm; Mandjes, Ingrid A. M.; Kemper, Inge; Onderwater, Suzanne; Chalabi, Myriam; Wilgenhof, Sofie; Haanen, John B. A. G., 0000-0001-5884-7704; Salgado, Roberto; De Visser, Karin E., 0000-0002-0293-868X; Sonke, Gabe S.; Wessels, Lodewyk F. A.; Linn, Sabine C.; Schumacher, Ton N., 0000-0003-0517-8804; Blank, Christian U.; Kok, Marleen, 0000-0001-9043-9815 Nature Medicine 2019
14694 10.1038/s41591-019-0542-z Resistance To Trk Inhibition Mediated By Convergent Mapk Pathway Activation Cocco, Emiliano; Schram, Alison M.; Kulick, Amanda; Misale, Sandra; Won, Helen H.; Yaeger, Rona; Razavi, Pedram; Ptashkin, Ryan; Hechtman, Jaclyn F.; Toska, Eneda; Cownie, James; Somwar, Romel; Shifman, Sophie; Mattar, Marissa; Selcuklu, S. Duygu; Samoila, Aliaksandra; Guzman, Sean; Tuch, Brian B.; Ebata, Kevin, 0000-0001-7166-7513; De Stanchina, Elisa; Nagy, Rebecca J.; Lanman, Richard B., 0000-0001-8122-4329; Houck-Loomis, Brian; Patel, Juber A.; Berger, Michael F.; Ladanyi, Marc; Hyman, David M., 0000-0001-8150-9762; Drilon, Alexander, 0000-0001-6806-9061; Scaltriti, Maurizio, 0000-0002-5522-1447 Nature Medicine 2019
14706 10.1038/s41591-019-0716-8 Antitumor Activity Of Crizotinib In Lung Cancers Harboring A Met Exon 14 Alteration Drilon, Alexander, 0000-0001-6806-9061; Clark, Jeffrey W.; Weiss, Jared; Ou, Sai-Hong Ignatius; Camidge, D. Ross; Solomon, Benjamin J.; Otterson, Gregory A.; Villaruz, Liza C.; Riely, Gregory J.; Heist, Rebecca S.; Awad, Mark M.; Shapiro, Geoffrey I.; Satouchi, Miyako; Hida, Toyoaki; Hayashi, Hidetoshi, 0000-0001-8787-5587; Murphy, Danielle A.; Wang, Sherry C.; Li, Sherry; Usari, Tiziana; Wilner, Keith D.; Paik, Paul K. Nature Medicine 2020
14904 10.1038/s41598-019-38534-6 Niraparib Activates Interferon Signaling And Potentiates Anti-Pd-1 Antibody Efficacy In Tumor Models Wang, Zebin; Sun, Kaiming; Xiao, Yonghong; Feng, Bin; Mikule, Keith; Ma, Xiaoyan; Feng, Ningping; Vellano, Christopher P.; Federico, Lorenzo; Marszalek, Joseph R.; Mills, Gordon B.; Hanke, Jeffrey; Ramaswamy, Sridhar; Wang, Jing Scientific Reports 2019
16034 10.1056/nejmoa1714448 Efficacy Of Larotrectinib Intrkfusion<U+2013>Positive Cancers In Adults And Children Drilon, Alexander; Laetsch, Theodore W.; Kummar, Shivaani; Dubois, Steven G.; Lassen, Ulrik N.; Demetri, George D.; Nathenson, Michael; Doebele, Robert C.; Farago, Anna F.; Pappo, Alberto S.; Turpin, Brian; Dowlati, Afshin; Brose, Marcia S.; Mascarenhas, Leo; Federman, Noah; Berlin, Jordan; El-Deiry, Wafik S.; Baik, Christina; Deeken, John; Boni, Valentina; Nagasubramanian, Ramamoorthy; Taylor, Matthew; Rudzinski, Erin R.; Meric-Bernstam, Funda; Sohal, Davendra P.S.; Ma, Patrick C.; Raez, Luis E.; Hechtman, Jaclyn F.; Benayed, Ryma; Ladanyi, Marc; Tuch, Brian B.; Ebata, Kevin; Cruickshank, Scott; Ku, Nora C.; Cox, Michael C.; Hawkins, Douglas S.; Hong, David S.; Hyman, David M., 0000-0001-8150-9762 New England Journal Of Medicine 2018
16057 10.1056/nejmoa1802905 Talazoparib In Patients With Advanced Breast Cancer And A Germline Brca Mutation Litton, Jennifer K.; Rugo, Hope S.; Ettl, Johannes; Hurvitz, Sara A.; Goncalves, Anthony; Lee, Kyung-Hun; Fehrenbacher, Louis; Yerushalmi, Rinat; Mina, Lida A.; Martin, Miguel; Roche, Henri; Im, Young-Hyuck; Quek, Ruben G.W.; Markova, Denka; Tudor, Iulia C.; Hannah, Alison L.; Eiermann, Wolfgang; Blum, Joanne L. New England Journal Of Medicine 2018
16069 10.1056/nejmoa1809615 Atezolizumab And Nab-Paclitaxel In Advanced Triple-Negative Breast Cancer Schmid, Peter; Adams, Sylvia; Rugo, Hope S.; Schneeweiss, Andreas; Barrios, Carlos H.; Iwata, Hiroji; Dieras, Veronique; Hegg, Roberto; Im, Seock-Ah; Shaw Wright, Gail; Henschel, Volkmar; Molinero, Luciana; Chui, Stephen Y.; Funke, Roel; Husain, Amreen; Winer, Eric P.; Loi, Sherene; Emens, Leisha A. New England Journal Of Medicine 2018
16073 10.1056/nejmoa1810171 Brigatinib Versus Crizotinib In Alk-Positive Non<U+2013>Small-Cell Lung Cancer Camidge, D. Ross; Kim, Hye Ryun; Ahn, Myung-Ju; Yang, James Chih-Hsin; Han, Ji-Youn; Lee, Jong-Seok; Hochmair, Maximilian J.; Li, Jacky Yu-Chung; Chang, Gee-Chen; Lee, Ki Hyeong; Gridelli, Cesare; Delmonte, Angelo; Garcia Campelo, Rosario; Kim, Dong-Wan; Bearz, Alessandra; Griesinger, Frank; Morabito, Alessandro; Felip, Enriqueta; Califano, Raffaele; Ghosh, Sharmistha; Spira, Alexander; Gettinger, Scott N.; Tiseo, Marcello; Gupta, Neeraj; Haney, Jeff; Kerstein, David; Popat, Sanjay New England Journal Of Medicine 2018
16075 10.1056/nejmoa1810858 Maintenance Olaparib In Patients With Newly Diagnosed Advanced Ovarian Cancer Moore, Kathleen; Colombo, Nicoletta; Scambia, Giovanni; Kim, Byoung-Gie; Oaknin, Ana; Friedlander, Michael; Lisyanskaya, Alla; Floquet, Anne; Leary, Alexandra; Sonke, Gabe S.; Gourley, Charlie; Banerjee, Susana; Oza, Amit; Gonzalez-Martin, Antonio; Aghajanian, Carol; Bradley, William; Mathews, Cara; Liu, Joyce; Lowe, Elizabeth S.; Bloomfield, Ralph; Disilvestro, Paul New England Journal Of Medicine 2018
16088 10.1056/nejmoa1814017 Trastuzumab Emtansine For Residual Invasive Her2-Positive Breast Cancer Von Minckwitz, Gunter; Huang, Chiun-Sheng; Mano, Max S.; Loibl, Sibylle; Mamounas, Eleftherios P.; Untch, Michael; Wolmark, Norman; Rastogi, Priya; Schneeweiss, Andreas; Redondo, Andres; Fischer, Hans H.; Jacot, William; Conlin, Alison K.; Arce-Salinas, Claudia; Wapnir, Irene L.; Jackisch, Christian; Digiovanna, Michael P.; Fasching, Peter A.; Crown, John P.; Wulfing, Pia; Shao, Zhimin; Rota Caremoli, Elena; Wu, Haiyan; Lam, Lisa H.; Tesarowski, David; Smitt, Melanie; Douthwaite, Hannah; Singel, Stina M.; Geyer, Charles E. New England Journal Of Medicine 2019
16090 10.1056/nejmoa1814213 Sacituzumab Govitecan-Hziy In Refractory Metastatic Triple-Negative Breast Cancer New England Journal Of Medicine 2019
16129 10.1056/nejmoa1909707 Veliparib With First-Line Chemotherapy And As Maintenance Therapy In Ovarian Cancer Coleman, Robert L.; Fleming, Gini F.; Brady, Mark F.; Swisher, Elizabeth M.; Steffensen, Karina D.; Friedlander, Michael; Okamoto, Aikou; Moore, Kathleen N.; Efrat Ben-Baruch, Noa; Werner, Theresa L.; Cloven, Noelle G.; Oaknin, Ana; Disilvestro, Paul A.; Morgan, Mark A.; Nam, Joo-Hyun; Leath, Charles A.; Nicum, Shibani; Hagemann, Andrea R.; Littell, Ramey D.; Cella, David; Baron-Hay, Sally; Garcia-Donas, Jesus; Mizuno, Mika; Bell-Mcguinn, Katherine; Sullivan, Danielle M.; Bach, Bruce A.; Bhattacharya, Sudipta; Ratajczak, Christine K.; Ansell, Peter J.; Dinh, Minh H.; Aghajanian, Carol; Bookman, Michael A. New England Journal Of Medicine 2019
16134 10.1056/nejmoa1910549 Pembrolizumab For Early Triple-Negative Breast Cancer New England Journal Of Medicine 2020
16137 10.1056/nejmoa1910962 Niraparib In Patients With Newly Diagnosed Advanced Ovarian Cancer New England Journal Of Medicine 2019
16142 10.1056/nejmoa1911361 Olaparib Plus Bevacizumab As First-Line Maintenance In Ovarian Cancer Ray-Coquard, Isabelle; Pautier, Patricia; Pignata, Sandro; Perol, David; Gonzalez-Martin, Antonio; Berger, Regina; Fujiwara, Keiichi; Vergote, Ignace; Colombo, Nicoletta; Maenpaa, Johanna; Selle, Frederic; Sehouli, Jalid; Lorusso, Domenica; Guerra Alia, Eva M.; Reinthaller, Alexander; Nagao, Shoji; Lefeuvre-Plesse, Claudia; Canzler, Ulrich; Scambia, Giovanni; Lortholary, Alain; Marme, Frederik; Combe, Pierre; De Gregorio, Nikolaus; Rodrigues, Manuel; Buderath, Paul; Dubot, Coraline; Burges, Alexander; You, Benoit; Pujade-Lauraine, Eric; Harter, Philipp New England Journal Of Medicine 2019
16147 10.1056/nejmoa1913662 Overall Survival With Osimertinib In Untreated, Egfr-Mutated Advanced Nsclc Ramalingam, Suresh S.; Vansteenkiste, Johan; Planchard, David; Cho, Byoung Chul; Gray, Jhanelle E.; Ohe, Yuichiro; Zhou, Caicun; Reungwetwattana, Thanyanan; Cheng, Ying; Chewaskulyong, Busyamas; Shah, Riyaz; Cobo, Manuel; Lee, Ki Hyeong; Cheema, Parneet; Tiseo, Marcello; John, Thomas; Lin, Meng-Chih; Imamura, Fumio; Kurata, Takayasu; Todd, Alexander; Hodge, Rachel; Saggese, Matilde; Rukazenkov, Yuri; Soria, Jean-Charles New England Journal Of Medicine 2020
16150 10.1056/nejmoa1914510 Trastuzumab Deruxtecan In Previously Treated Her2-Positive Breast Cancer Modi, Shanu; Saura, Cristina; Yamashita, Toshinari; Park, Yeon Hee; Kim, Sung-Bae; Tamura, Kenji; Andre, Fabrice; Iwata, Hiroji; Ito, Yoshinori; Tsurutani, Junji; Sohn, Joohyuk; Denduluri, Neelima; Perrin, Christophe; Aogi, Kenjiro; Tokunaga, Eriko; Im, Seock-Ah; Lee, Keun Seok; Hurvitz, Sara A.; Cortes, Javier; Lee, Caleb; Chen, Shuquan; Zhang, Lin; Shahidi, Javad; Yver, Antoine; Krop, Ian New England Journal Of Medicine 2020
16151 10.1056/nejmoa1914609 Tucatinib, Trastuzumab, And Capecitabine For Her2-Positive Metastatic Breast Cancer Murthy, Rashmi K.; Loi, Sherene; Okines, Alicia; Paplomata, Elisavet; Hamilton, Erika; Hurvitz, Sara A.; Lin, Nancy U.; Borges, Virginia; Abramson, Vandana; Anders, Carey; Bedard, Philippe L.; Oliveira, Mafalda; Jakobsen, Erik; Bachelot, Thomas; Shachar, Shlomit S.; Muller, Volkmar; Braga, Sofia; Duhoux, Francois P., 0000-0002-5429-7888; Greil, Richard; Cameron, David; Carey, Lisa A.; Curigliano, Giuseppe; Gelmon, Karen; Hortobagyi, Gabriel; Krop, Ian; Loibl, Sibylle; Pegram, Mark; Slamon, Dennis; Palanca-Wessels, M. Corinna; Walker, Luke; Feng, Wentao; Winer, Eric P. New England Journal Of Medicine 2020
16165 10.1056/nejmoa2002787 Capmatinib Inmetexon 14<U+2013>Mutated Ormet-Amplified Non<U+2013>Small-Cell Lung Cancer Wolf, Jurgen; Seto, Takashi; Han, Ji-Youn; Reguart, Noemi; Garon, Edward B.; Groen, Harry J.M.; Tan, Daniel S.W.; Hida, Toyoaki; De Jonge, Maja; Orlov, Sergey V.; Smit, Egbert F.; Souquet, Pierre-Jean; Vansteenkiste, Johan; Hochmair, Maximilian; Felip, Enriqueta; Nishio, Makoto; Thomas, Michael; Ohashi, Kadoaki; Toyozawa, Ryo; Overbeck, Tobias R.; De Marinis, Filippo; Kim, Tae-Min, 0000-0001-6145-4426; Laack, Eckart; Robeva, Anna; Le Mouhaer, Sylvie; Waldron-Lynch, Maeve; Sankaran, Banu; Balbin, O. Alejandro; Cui, Xiaoming; Giovannini, Monica; Akimov, Mikhail; Heist, Rebecca S. New England Journal Of Medicine 2020
16169 10.1056/nejmoa2004407 Tepotinib In Non<U+2013>Small-Cell Lung Cancer With Met Exon 14 Skipping Mutations Paik, Paul K.; Felip, Enriqueta; Veillon, Remi; Sakai, Hiroshi; Cortot, Alexis B.; Garassino, Marina C.; Mazieres, Julien; Viteri, Santiago; Senellart, Helene; Van Meerbeeck, Jan; Raskin, Jo; Reinmuth, Niels; Conte, Pierfranco; Kowalski, Dariusz; Cho, Byoung Chul; Patel, Jyoti D.; Horn, Leora; Griesinger, Frank; Han, Ji-Youn; Kim, Young-Chul, 0000-0001-7019-7687; Chang, Gee-Chen; Tsai, Chen-Liang; Yang, James C.-H.; Chen, Yuh-Min; Smit, Egbert F.; Van Der Wekken, Anthonie J.; Kato, Terufumi; Juraeva, Dilafruz; Stroh, Christopher; Bruns, Rolf; Straub, Josef; Johne, Andreas; Scheele, Jurgen; Heymach, John V.; Le, Xiuning New England Journal Of Medicine 2020
16170 10.1056/nejmoa2004413 Trastuzumab Deruxtecan In Previously Treated Her2-Positive Gastric Cancer Shitara, Kohei; Bang, Yung-Jue; Iwasa, Satoru; Sugimoto, Naotoshi; Ryu, Min-Hee; Sakai, Daisuke; Chung, Hyun-Cheol; Kawakami, Hisato; Yabusaki, Hiroshi; Lee, Jeeyun; Saito, Kaku; Kawaguchi, Yoshinori; Kamio, Takahiro; Kojima, Akihito; Sugihara, Masahiro; Yamaguchi, Kensei New England Journal Of Medicine 2020
16176 10.1056/nejmoa2005651 Efficacy Of Selpercatinib In Ret-Altered Thyroid Cancers Wirth, Lori J., 0000-0002-2629-2289; Sherman, Eric; Robinson, Bruce; Solomon, Benjamin; Kang, Hyunseok, 0000-0001-5758-8202; Lorch, Jochen; Worden, Francis; Brose, Marcia; Patel, Jyoti; Leboulleux, Sophie; Godbert, Yann; Barlesi, Fabrice; Morris, John C.; Owonikoko, Taofeek K.; Tan, Daniel S.W.; Gautschi, Oliver; Weiss, Jared; De La Fouchardiere, Christelle; Burkard, Mark E.; Laskin, Janessa; Taylor, Matthew H.; Kroiss, Matthias, 0000-0002-7628-3161; Medioni, Jacques; Goldman, Jonathan W.; Bauer, Todd M.; Levy, Benjamin; Zhu, Viola W.; Lakhani, Nehal; Moreno, Victor; Ebata, Kevin; Nguyen, Michele; Heirich, Dana; Zhu, Edward Y.; Huang, Xin; Yang, Luxi; Kherani, Jennifer; Rothenberg, S. Michael; Drilon, Alexander; Subbiah, Vivek, 0000-0002-6064-6837; Shah, Manisha H.; Cabanillas, Maria E., 0000-0002-5124-1811 New England Journal Of Medicine 2020
16177 10.1056/nejmoa2005653 Efficacy Of Selpercatinib In Ret Fusion<U+2013>Positive Non<U+2013>Small-Cell Lung Cancer Drilon, Alexander; Oxnard, Geoffrey R.; Tan, Daniel S.W.; Loong, Herbert H.F., 0000-0002-6607-1106; Johnson, Melissa; Gainor, Justin; Mccoach, Caroline E.; Gautschi, Oliver; Besse, Benjamin; Cho, Byoung C.; Peled, Nir; Weiss, Jared; Kim, Yu-Jung; Ohe, Yuichiro; Nishio, Makoto; Park, Keunchil; Patel, Jyoti; Seto, Takashi; Sakamoto, Tomohiro; Rosen, Ezra; Shah, Manisha H.; Barlesi, Fabrice; Cassier, Philippe A.; Bazhenova, Lyudmila; De Braud, Filippo; Garralda, Elena; Velcheti, Vamsidhar; Satouchi, Miyako; Ohashi, Kadoaki; Pennell, Nathan A.; Reckamp, Karen L.; Dy, Grace K.; Wolf, Jurgen; Solomon, Benjamin; Falchook, Gerald; Ebata, Kevin; Nguyen, Michele; Nair, Binoj; Zhu, Edward Y.; Yang, Luxi; Huang, Xin; Olek, Elizabeth; Rothenberg, S. Michael; Goto, Koichi; Subbiah, Vivek, 0000-0002-6064-6837 New England Journal Of Medicine 2020
16205 10.1056/nejmoa2027071 Osimertinib In Resected Egfr-Mutated Non<U+2013>Small-Cell Lung Cancer Wu, Yi-Long; Tsuboi, Masahiro; He, Jie; John, Thomas; Grohe, Christian; Majem, Margarita; Goldman, Jonathan W.; Laktionov, Konstantin; Kim, Sang-We; Kato, Terufumi; Vu, Huu-Vinh; Lu, Shun; Lee, Kye-Young; Akewanlop, Charuwan; Yu, Chong-Jen; De Marinis, Filippo; Bonanno, Laura; Domine, Manuel; Shepherd, Frances A.; Zeng, Lingmin; Hodge, Rachel; Atasoy, Ajlan; Rukazenkov, Yuri; Herbst, Roy S. New England Journal Of Medicine 2020
16206 10.1056/nejmoa2027187 First-Line Lorlatinib Or Crizotinib In Advanced Alk-Positive Lung Cancer Shaw, Alice T.; Bauer, Todd M.; De Marinis, Filippo; Felip, Enriqueta; Goto, Yasushi; Liu, Geoffrey; Mazieres, Julien; Kim, Dong-Wan; Mok, Tony; Polli, Anna; Thurm, Holger; Calella, Anna M.; Peltz, Gerson; Solomon, Benjamin J. New England Journal Of Medicine 2020
16221 10.1056/nejmoa2032125 Adjuvant Nivolumab In Resected Esophageal Or Gastroesophageal Junction Cancer Kelly, Ronan J.; Ajani, Jaffer A., 0000-0001-9946-0629; Kuzdzal, Jaroslaw; Zander, Thomas; Van Cutsem, Eric; Piessen, Guillaume, 0000-0001-8243-8310; Mendez, Guillermo; Feliciano, Josephine; Motoyama, Satoru; Lievre, Astrid; Uronis, Hope; Elimova, Elena; Grootscholten, Cecile; Geboes, Karen; Zafar, Syed; Snow, Stephanie; Ko, Andrew H.; Feeney, Kynan; Schenker, Michael; Kocon, Piotr; Zhang, Jenny; Zhu, Lili; Lei, Ming; Singh, Prianka; Kondo, Kaoru; Cleary, James M.; Moehler, Markus New England Journal Of Medicine 2021
16242 10.1056/nejmoa2105215 Adjuvant Olaparib For Patients With Brca1- Or Brca2-Mutated Breast Cancer Tutt, Andrew N.J., 0000-0001-8715-2901; Garber, Judy E.; Kaufman, Bella; Viale, Giuseppe; Fumagalli, Debora; Rastogi, Priya; Gelber, Richard D.; De Azambuja, Evandro, 0000-0001-9501-4509; Fielding, Anitra; Balmana, Judith; Domchek, Susan M.; Gelmon, Karen A.; Hollingsworth, Simon J.; Korde, Larissa A.; Linderholm, Barbro; Bandos, Hanna; Senkus, El<U+017C>bieta; Suga, Jennifer M.; Shao, Zhimin; Pippas, Andrew W.; Nowecki, Zbigniew; Huzarski, Tomasz; Ganz, Patricia A.; Lucas, Peter C.; Baker, Nigel; Loibl, Sibylle; Mcconnell, Robin; Piccart, Martine; Schmutzler, Rita; Steger, Guenther G.; Costantino, Joseph P.; Arahmani, Amal; Wolmark, Norman; Mcfadden, Eleanor; Karantza, Vassiliki; Lakhani, Sunil R.; Yothers, Greg; Campbell, Christine; Geyer, Charles E., 0000-0002-2379-5702 New England Journal Of Medicine 2021
16940 10.1089/thy.2019.0133 Complete Surgical Resection Following Neoadjuvant Dabrafenib Plus Trametinib Inbrafv600E-Mutated Anaplastic Thyroid Carcinoma Wang, Jennifer R.; Zafereo, Mark E.; Dadu, Ramona; Ferrarotto, Renata; Busaidy, Naifa L.; Lu, Charles; Ahmed, Salmaan; Gule-Monroe, Maria K.; Williams, Michelle D.; Sturgis, Erich M.; Goepfert, Ryan P.; Gross, Neil D.; Lai, Stephen Y.; Gunn, Gary Brandon; Phan, Jack; Rosenthal, David I.; Fuller, Clifton David; Morrison, William H.; Iyer, Priyanka; Cabanillas, Maria E. Thyroid 2019
16959 10.1093/annonc/mdy264 Bang, Y.-J; Ruiz, E.Yanez; Van Cutsem, E.; Lee, K.-W; Wyrwicz, L.; Schenker, M.; Alsina, M.; Ryu, M.-H; Chung, H.-C; Evesque, L.; Al-Batran, S.-E; Park, S.H.; Lichinitser, M.; Boku, N.; Moehler, M.H.; Hong, J.; Xiong, H.; Hallwachs, R.; Conti, I.; Taieb, J. Annals Of Oncology 2018
16960 10.1093/annonc/mdy334 Pd-L1 Expression, Tumor Mutational Burden, And Response To Immunotherapy In Patients With Met Exon 14 Altered Lung Cancers Sabari, J.K., 0000-0002-1556-1543; Leonardi, G.C.; Shu, C.A.; Umeton, R.; Montecalvo, J.; Ni, A.; Chen, R.; Dienstag, J.; Mrad, C.; Bergagnini, I.; Lai, W.V.; Offin, M.; Arbour, K.C.; Plodkowski, A.J.; Halpenny, D.F.; Paik, P.K.; Li, B.T.; Riely, G.J.; Kris, M.G.; Rudin, C.M.; Sholl, L.M.; Nishino, M.; Hellmann, M.D.; Rekhtman, N.; Awad, M.M.; Drilon, A. Annals Of Oncology 2018
16961 10.1093/annonc/mdy405 Alectinib Versus Crizotinib In Treatment-Naive Anaplastic Lymphoma Kinase-Positive (Alk+) Non-Small-Cell Lung Cancer: Cns Efficacy Results From The Alex Study Gadgeel, S.; Peters, S., 0000-0002-0412-7143; Mok, T.; Shaw, A.T.; Kim, D.W.; Ou, S.I.; Perol, M.; Wrona, A.; Novello, S.; Rosell, R.; Zeaiter, A.; Liu, T.; Nuesch, E.; Balas, B.; Camidge, D.R. Annals Of Oncology 2018
16962 10.1093/annonc/mdy424.063 Mechanisms Of Acquired Resistance To First-Line Osimertinib: Preliminary Data From The Phase Iii Flaura Study Ramalingam, S.S.; Cheng, Y.; Zhou, C.; Ohe, Y.; Imamura, F.; Cho, B.C.; Lin, M.-C.; Majem, M.; Shah, R.; Rukazenkov, Y.; Todd, A.; Markovets, A.; Barrett, J.C.; Chmielecki, J.; Gray, J. Annals Of Oncology 2018
16963 10.1093/annonc/mdy424.064 Analysis Of Resistance Mechanisms To Osimertinib In Patients With Egfr T790M Advanced Nsclc From The Aura3 Study Papadimitrakopoulou, V.A.; Wu, Y.-L.; Han, J.-Y.; Ahn, M.-J.; Ramalingam, S.S.; John, T.; Okamoto, I.; Yang, J.C.-H.; Bulusu, K.C.; Laus, G.; Collins, B.; Barrett, J.C.; Chmielecki, J.; Mok, T.S.K. Annals Of Oncology 2018
16964 10.1093/annonc/mdy460 Loibl, S.; Weber, K.E.; Timms, K.M.; Elkin, E.P.; Hahnen, E.; Fasching, P.A.; Lederer, B.; Denkert, C.; Schneeweiss, A.; Braun, S.; Salat, C.T.; Rezai, M.; Blohmer, J.U.; Zahm, D.M.; Jackisch, C.; Gerber, B.; Klare, P.; Kummel, S.; Schem, C.; Paepke, S.; Schmutzler, R.; Rhiem, K.; Penn, S.; Reid, J.; Nekljudova, V.; Hartman, A.-R.; Von Minckwitz, G.; Untch, M. Annals Of Oncology 2018
16965 10.1093/annonc/mdy517 Pembrolizumab Monotherapy For Previously Treated Metastatic Triple-Negative Breast Cancer: Cohort A Of The Phase Ii Keynote-086 Study Annals Of Oncology 2019
16966 10.1093/annonc/mdy518 Pembrolizumab Monotherapy For Previously Untreated, Pd-L1-Positive, Metastatic Triple-Negative Breast Cancer: Cohort B Of The Phase Ii Keynote-086 Study Adams, S.; Loi, S.; Toppmeyer, D.; Cescon, D.W.; De Laurentiis, M.; Nanda, R.; Winer, E.P.; Mukai, H.; Tamura, K.; Armstrong, A.; Liu, M.C.; Iwata, H.; Ryvo, L.; Wimberger, P.; Rugo, H.S.; Tan, A.R.; Jia, L.; Ding, Y.; Karantza, V.; Schmid, P. Annals Of Oncology 2019
16967 10.1093/annonc/mdy539 Larotrectinib In Adult Patients With Solid Tumours: A Multi-Centre, Open-Label, Phase I Dose-Escalation Study Hong, D.S.; Bauer, T.M.; Lee, J.J.; Dowlati, A.; Brose, M.S.; Farago, A.F.; Taylor, M.; Shaw, A.T.; Montez, S.; Meric-Bernstam, F.; Smith, S.; Tuch, B.B.; Ebata, K.; Cruickshank, S.; Cox, M.C.; Burris, H.A.; Doebele, R.C. Annals Of Oncology 2019
16968 10.1093/annonc/mdy540 Safety And Efficacy Of Nivolumab In Combination With S-1/Capecitabine Plus Oxaliplatin In Patients With Previously Untreated, Unresectable, Advanced, Or Recurrent Gastric/Gastroesophageal Junction Cancer: Interim Results Of A Randomized, Phase Ii Trial (Attraction-4) Boku, N.; Ryu, M.-H.; Kato, K.; Chung, H.C.; Minashi, K.; Lee, K.-W.; Cho, H.; Kang, W.K.; Komatsu, Y.; Tsuda, M.; Yamaguchi, K.; Hara, H.; Fumita, S.; Azuma, M.; Chen, L.-T.; Kang, Y.-K. Annals Of Oncology 2019
16969 10.1093/annonc/mdy542 Her2 Exon 20 Insertions In Non-Small-Cell Lung Cancer Are Sensitive To The Irreversible Pan-Her Receptor Tyrosine Kinase Inhibitor Pyrotinib Wang, Y.; Jiang, T.; Qin, Z.; Jiang, J.; Wang, Q.; Yang, S.; Rivard, C.; Gao, G.; Ng, T.L.; Tu, M.M.; Yu, H.; Ji, H.; Zhou, C.; Ren, S.; Zhang, J.; Bunn, P.; Doebele, R.C.; Camidge, D.R.; Hirsch, F.R. Annals Of Oncology 2019
16970 10.1093/annonc/mdy547 Prognostic Implications Of Residual Disease Tumor-Infiltrating Lymphocytes And Residual Cancer Burden In Triple-Negative Breast Cancer Patients After Neoadjuvant Chemotherapy Annals Of Oncology 2019
16973 10.1093/annonc/mdz012 Robson, M.E., 0000-0002-3109-1692; Tung, N.; Conte, P., 0000-0002-5210-5344; Im, S.-A.; Senkus, E.; Xu, B.; Masuda, N.; Delaloge, S.; Li, W.; Armstrong, A.; Wu, W.; Goessl, C.; Runswick, S.; Domchek, S.M. Annals Of Oncology 2019
16974 10.1093/annonc/mdz018 Overall Survival And Updated Progression-Free Survival Outcomes In A Randomized Phase Ii Study Of Combination Cediranib And Olaparib Versus Olaparib In Relapsed Platinum-Sensitive Ovarian Cancer Liu, J.F.; Barry, W.T.; Birrer, M.; Lee, J.-M.; Buckanovich, R.J.; Fleming, G.F.; Rimel, B.J.; Buss, M.K.; Nattam, S.R.; Hurteau, J.; Luo, W.; Curtis, J.; Whalen, C.; Kohn, E.C.; Ivy, S.P.; Matulonis, U.A. Annals Of Oncology 2019
16976 10.1093/annonc/mdz077 Severe Immune-Related Adverse Events Are Common With Sequential Pd-(L)1 Blockade And Osimertinib Schoenfeld, A.J., 0000-0002-2644-1416; Arbour, K.C.; Rizvi, H.; Iqbal, A.N.; Gadgeel, S.M.; Girshman, J.; Kris, M.G.; Riely, G.J.; Yu, H.A.; Hellmann, M.D. Annals Of Oncology 2019
16981 10.1093/annonc/mdz131 Crizotinib In Ros1-Rearranged Advanced Non-Small-Cell Lung Cancer (Nsclc): Updated Results, Including Overall Survival, From Profile 1001 Shaw, A.T.; Riely, G.J.; Bang, Y.-J.; Kim, D.-W.; Camidge, D.R.; Solomon, B.J.; Varella-Garcia, M.; Iafrate, A.J.; Shapiro, G.I.; Usari, T.; Wang, S.C.; Wilner, K.D.; Clark, J.W.; Ou, S.-H.I. Annals Of Oncology 2019
16982 10.1093/annonc/mdz135 Antitumor Activity And Safety Of Pembrolizumab In Patients With Advanced Recurrent Ovarian Cancer: Results From The Phase Ii Keynote-100 Study Matulonis, U.A.; Shapira-Frommer, R.; Santin, A.D.; Lisyanskaya, A.S.; Pignata, S.; Vergote, I., 0000-0002-7589-8981; Raspagliesi, F.; Sonke, G.S.; Birrer, M.; Provencher, D.M.; Sehouli, J.; Colombo, N.; Gonzalez-Martin, A.; Oaknin, A.; Ottevanger, P.B.; Rudaitis, V.; Katchar, K.; Wu, H.; Keefe, S.; Ruman, J.; Ledermann, J.A. Annals Of Oncology 2019
16983 10.1093/annonc/mdz158 A Randomised Phase Ii Study Investigating Durvalumab In Addition To An Anthracycline Taxane-Based Neoadjuvant Therapy In Early Triple-Negative Breast Cancer: Clinical Results And Biomarker Analysis Of Geparnuevo Study Loibl, S., 0000-0003-4885-8471; Untch, M.; Burchardi, N.; Huober, J.; Sinn, B.V.; Blohmer, J.-U.; Grischke, E.-M.; Furlanetto, J.; Tesch, H.; Hanusch, C.; Engels, K.; Rezai, M.; Jackisch, C.; Schmitt, W.D.; Von Minckwitz, G.; Thomalla, J.; Kummel, S.; Rautenberg, B.; Fasching, P.A.; Weber, K.; Rhiem, K.; Denkert, C.; Schneeweiss, A. Annals Of Oncology 2019
16984 10.1093/annonc/mdz167 Immune Checkpoint Inhibitors For Patients With Advanced Lung Cancer And Oncogenic Driver Alterations: Results From The Immunotarget Registry Mazieres, J., 0000-0002-1556-1543; Drilon, A.; Lusque, A.; Mhanna, L.; Cortot, A.B.; Mezquita, L.; Thai, A.A.; Mascaux, C.; Couraud, S.; Veillon, R.; Van Den Heuvel, M.; Neal, J.; Peled, N.; Fruh, M.; Ng, T.L.; Gounant, V.; Popat, S.; Diebold, J.; Sabari, J.; Zhu, V.W.; Rothschild, S.I.; Bironzo, P.; Martinez-Marti, A.; Curioni-Fontecedro, A.; Rosell, R.; Lattuca-Truc, M.; Wiesweg, M.; Besse, B.; Solomon, B.; Barlesi, F.; Schouten, R.D.; Wakelee, H.; Camidge, D.R.; Zalcman, G.; Novello, S.; Ou, S.I.; Milia, J.; Gautschi, O. Annals Of Oncology 2019
16986 10.1093/annonc/mdz197 Safety, Efficacy And Tumor Mutational Burden As A Biomarker Of Overall Survival Benefit In Chemo-Refractory Gastric Cancer Treated With Toripalimab, A Pd-1 Antibody In Phase Ib/Ii Clinical Trial Nct02915432 Wang, F., 0000-0001-9771-8534; Wei, X.L.; Wang, F.H.; Xu, N.; Shen, L.; Dai, G.H.; Yuan, X.L.; Chen, Y.; Yang, S.J.; Shi, J.H.; Hu, X.C.; Lin, X.Y.; Zhang, Q.Y.; Feng, J.F.; Ba, Y.; Liu, Y.P.; Li, W.; Shu, Y.Q.; Jiang, Y.; Li, Q.; Wang, J.W.; Wu, H.; Feng, H.; Yao, S.; Xu, R.H. Annals Of Oncology 2019
16987 10.1093/annonc/mdz204 Esmo Recommendations On The Standard Methods To Detect Ntrk Fusions In Daily Practice And Clinical Research Marchio, C., 0000-0002-5522-1447; Scaltriti, M.; Ladanyi, M.; Iafrate, A.J.; Bibeau, F.; Dietel, M.; Hechtman, J.F.; Troiani, T.; Lopez-Rios, F.; Douillard, J.-Y.; Andre, F.; Reis-Filho, J.S. Annals Of Oncology 2019
16988 10.1093/annonc/mdz282 Trk Inhibitors In Trk Fusion-Positive Cancers Drilon, A. Annals Of Oncology 2019
16990 10.1093/annonc/mdz384 Identifying Patients With Ntrk Fusion Cancer Solomon, J.P.; Benayed, R.; Hechtman, J.F.; Ladanyi, M. Annals Of Oncology 2019
16992 10.1093/annonc/mdz395 Prognostic Value Of Tumor-Infiltrating Lymphocytes In Patients With Early-Stage Triple-Negative Breast Cancers (Tnbc) Who Did Not Receive Adjuvant Chemotherapy Park, J H, 0000-0002-6963-2968; Jonas, S F; Bataillon, G; Criscitiello, C; Salgado, R; Loi, S; Viale, G; Lee, H J; Dieci, M V; Kim, S -B; Vincent-Salomon, A; Curigliano, G; Andre, F; Michiels, S Annals Of Oncology 2019
16996 10.1093/annonc/mdz407 Crizotinib In C-Met- Or Ros1-Positive Nsclc: Results Of The Acse Phase Ii Trial Moro-Sibilot, D.; Cozic, N.; Perol, M.; Mazieres, J.; Otto, J.; Souquet, P.J.; Bahleda, R.; Wislez, M.; Zalcman, G.; Guibert, S.D.; Barlesi, F.; Mennecier, B.; Monnet, I.; Sabatier, R.; Bota, S.; Dubos, C.; Verriele, V.; Haddad, V.; Ferretti, G.; Cortot, A.; De Fraipont, F.; Jimenez, M.; Hoog-Labouret, N.; Vassal, G. Annals Of Oncology 2019
17450 10.1097/pas.0000000000001203 Expanding The Spectrum Of Pediatric Ntrk-Rearranged Mesenchymal Tumors Davis, Jessica L.; Lockwood, Christina M.; Stohr, Bradley; Boecking, Carolin; Al-Ibraheemi, Alyaa; Dubois, Steven G.; Vargas, Sara O.; Black, Jennifer O.; Cox, Michael C.; Luquette, Mark; Turpin, Brian; Szabo, Sara; Laetsch, Theodore W.; Albert, Catherine M.; Parham, David M.; Hawkins, Douglas S.; Rudzinski, Erin R. American Journal Of Surgical Pathology 2019
19087 10.1126/scitranslmed.aav4508 Cediranib Suppresses Homology-Directed Dna Repair Through Down-Regulation Of Brca1/2 And Rad51 Kaplan, Alanna R., 0000-0002-2612-4736; Gueble, Susan E., 0000-0002-8043-1147; Liu, Yanfeng; Oeck, Sebastian, 0000-0001-9695-8771; Kim, Hoon; Yun, Zhong, 0000-0003-4123-747X; Glazer, Peter M., 0000-0003-4525-5560 Science Translational Medicine 2019
19272 10.1136/jclinpath-2018-205679 Testing Algorithm For Identification Of Patients With Trk Fusion Cancer Penault-Llorca, Frederique, 0000-0002-4279-5492; Rudzinski, Erin R; Sepulveda, Antonia R Journal Of Clinical Pathology 2019
19479 10.1158/0008-5472.can-18-1003 Parpi Triggers The Sting-Dependent Immune Response And Enhances The Therapeutic Efficacy Of Immune Checkpoint Blockade Independent Of Brcaness Shen, Jianfeng; Zhao, Wei; Ju, Zhenlin; Wang, Lulu; Peng, Yang; Labrie, Marilyne; Yap, Timothy A.; Mills, Gordon B.; Peng, Guang Cancer Research 2018
19480 10.1158/0008-5472.can-18-2652 Development Of Parp And Immune-Checkpoint Inhibitor Combinations Stewart, Ross A; Pilie, Patrick G; Yap, Timothy A Cancer Research 2018
19485 10.1158/0008-5472.can-18-3126 Colorectal Carcinomas Containing Hypermethylated Mlh1 Promoter And Wild-Type Braf/Kras Are Enriched For Targetable Kinase Fusions Cocco, Emiliano; Benhamida, Jamal; Middha, Sumit; Zehir, Ahmet, 0000-0001-5406-4104; Mullaney, Kerry; Shia, Jinru; Yaeger, Rona; Zhang, Liying, 0000-0003-4517-0751; Wong, Donna, 0000-0001-8154-0858; Villafania, Liliana; Nafa, Khedoudja; Scaltriti, Maurizio; Drilon, Alexander, 0000-0001-6806-9061; Saltz, Leonard, 0000-0001-8353-4670; Schram, Alison M., 0000-0002-6070-2413; Stadler, Zsofia K.; Hyman, David M.; Benayed, Ryma; Ladanyi, Marc; Hechtman, Jaclyn F. Cancer Research 2019
19489 10.1158/0008-5472.can-19-0372 Detection Of Ntrk Fusions: Merits And Limitations Of Current Diagnostic Platforms Solomon, James P.; Hechtman, Jaclyn F. Cancer Research 2019
19499 10.1158/1078-0432.ccr-18-1542 Landscape Of Egfr-Dependent And -Independent Resistance Mechanisms To Osimertinib And Continuation Therapy Beyond Progression In Egfr-Mutant Nsclc Le, Xiuning; Puri, Sonam; Negrao, Marcelo V.; Nilsson, Monique B.; Robichaux, Jacqulyne; Boyle, Theresa; Hicks, J. Kevin, 0000-0003-2314-0164; Lovinger, Katherine L.; Roarty, Emily; Rinsurongkawong, Waree; Tang, Ming; Sun, Huiying; Elamin, Yasir; Lacerda, Lara C.; Lewis, Jeff; Roth, Jack A.; Swisher, Stephen G., 0000-0002-3080-1920; Lee, J. Jack; William, William N.; Glisson, Bonnie S.; Zhang, Jianjun; Papadimitrakopoulou, Vassiliki A.; Gray, Jhanelle E.; Heymach, John V., 0000-0001-9068-8942 Clinical Cancer Research 2018
19506 10.1158/1078-0432.ccr-18-2814 Capmatinib (Inc280) Is Active Against Models Of Non<U+2013>Small Cell Lung Cancer And Other Cancer Types With Defined Mechanisms Of Met Activation Baltschukat, Sabrina; Engstler, Barbara Schacher; Huang, Alan; Hao, Huai-Xiang; Tam, Angela; Wang, Hui Qin; Liang, Jinsheng; Dimare, Matthew T.; Bhang, Hyo-Eun Carrie; Wang, Youzhen; Furet, Pascal; Sellers, William R., 0000-0002-3539-9803; Hofmann, Francesco; Schoepfer, Joseph, 0000-0001-7935-1767; Tiedt, Ralph Clinical Cancer Research 2019
19511 10.1158/1078-0432.ccr-19-0225 High Yield Of Rna Sequencing For Targetable Kinase Fusions In Lung Adenocarcinomas With No Mitogenic Driver Alteration Detected By Dna Sequencing And Low Tumor Mutation Burden Benayed, Ryma, 0000-0002-3754-0321; Offin, Michael, 0000-0002-7959-3018; Mullaney, Kerry; Sukhadia, Purvil, 0000-0002-6079-0871; Rios, Kelly, 0000-0001-7596-0741; Desmeules, Patrice; Ptashkin, Ryan, 0000-0003-4275-5500; Won, Helen; Chang, Jason; Halpenny, Darragh; Schram, Alison M., 0000-0002-6070-2413; Rudin, Charles M., 0000-0001-5204-3465; Hyman, David M.; Arcila, Maria E.; Berger, Michael F.; Zehir, Ahmet, 0000-0001-5406-4104; Kris, Mark G.; Drilon, Alexander, 0000-0001-6806-9061; Ladanyi, Marc Clinical Cancer Research 2019
19513 10.1158/1078-0432.ccr-19-0994 Crizotinib In Met-Deregulated Or Ros1-Rearranged Pretreated Non<U+2013>Small Cell Lung Cancer (Metros): A Phase Ii, Prospective, Multicenter, Two-Arms Trial Landi, Lorenza; Chiari, Rita; Tiseo, Marcello; D’Inca, Federica; Dazzi, Claudio; Chella, Antonio; Delmonte, Angelo; Bonanno, Laura, 0000-0001-5218-4970; Giannarelli, Diana; Cortinovis, Diego Luigi; De Marinis, Filippo; Borra, Gloria; Morabito, Alessandro; Gridelli, Cesare; Galetta, Domenico; Barbieri, Fausto; Grossi, Francesco; Capelletto, Enrica, 0000-0003-2070-9335; Minuti, Gabriele; Mazzoni, Francesca; Verusio, Claudio, 0000-0003-3283-6868; Bria, Emilio, 0000-0002-2333-704X; Ali, Greta; Bruno, Rossella, 0000-0003-4965-1501; Proietti, Agnese; Fontanini, Gabriella; Crino, Lucio; Cappuzzo, Federico Clinical Cancer Research 2019
19520 10.1158/1078-0432.ccr-19-3563 Tumor Analyses Reveal Squamous Transformation And Off-Target Alterations As Early Resistance Mechanisms To First-Line Osimertinib In Egfr-Mutant Lung Cancer Schoenfeld, Adam J., 0000-0002-2644-1416; Chan, Joseph M.; Kubota, Daisuke; Sato, Hiroki; Rizvi, Hira; Daneshbod, Yahya; Chang, Jason C.; Paik, Paul K.; Offin, Michael, 0000-0002-7959-3018; Arcila, Maria E.; Davare, Monika A.; Shinde, Ujwal; Pe’Er, Dana; Rekhtman, Natasha, 0000-0001-5801-3144; Kris, Mark G.; Somwar, Romel; Riely, Gregory J.; Ladanyi, Marc; Yu, Helena A. Clinical Cancer Research 2020
19528 10.1158/2159-8290.cd-18-0484 Repotrectinib (Tpx-0005) Is A Next-Generation Ros1/Trk/Alk Inhibitor That Potently Inhibits Ros1/Trk/Alk Solvent- Front Mutations Drilon, Alexander; Ou, Sai-Hong Ignatius; Cho, Byoung Chul; Kim, Dong-Wan; Lee, Jeeyun; Lin, Jessica J., 0000-0001-7373-3916; Zhu, Viola W.; Ahn, Myung-Ju; Camidge, D. Ross; Nguyen, Judy; Zhai, Dayong; Deng, Wei; Huang, Zhongdong; Rogers, Evan; Liu, Juliet; Whitten, Jeff; Lim, John K.; Stopatschinskaja, Shanna; Hyman, David M.; Doebele, Robert C., 0000-0001-6728-6857; Cui, J. Jean; Shaw, Alice T. Cancer Discovery 2018
19529 10.1158/2159-8290.cd-18-0598 Egfr And Met Amplifications Determine Response To Her2 Inhibition In Erbb2-Amplified Esophagogastric Cancer Sanchez-Vega, Francisco; Hechtman, Jaclyn F.; Castel, Pau; Ku, Geoffrey Y., 0000-0002-0448-1038; Tuvy, Yaelle; Won, Helen; Fong, Christopher J.; Bouvier, Nancy; Nanjangud, Gouri J.; Soong, Joanne; Vakiani, Efsevia; Schattner, Mark; Kelsen, David P.; Lefkowitz, Robert A.; Brown, Karen; Lacouture, Mario E.; Capanu, Marinela; Mattar, Marissa; Qeriqi, Besnik; Cecchi, Fabiola; Tian, Yuan; Hembrough, Todd; Nagy, Rebecca J.; Lanman, Richard B., 0000-0001-8122-4329; Larson, Steven M.; Pandit-Taskar, Neeta; Schoder, Heiko; Iacobuzio-Donahue, Christine A., 0000-0002-4672-3023; Ilson, David H.; Weber, Wolfgang A.; Berger, Michael F.; De Stanchina, Elisa; Taylor, Barry S.; Lewis, Jason S., 0000-0001-7065-4534; Solit, David B.; Carrasquillo, Jorge A.; Scaltriti, Maurizio; Schultz, Nikolaus; Janjigian, Yelena Y. Cancer Discovery 2018
19531 10.1158/2159-8290.cd-18-0715 Brca Reversion Mutations In Circulating Tumor Dna Predict Primary And Acquired Resistance To The Parp Inhibitor Rucaparib In High-Grade Ovarian Carcinoma Lin, Kevin K.; Harrell, Maria I.; Oza, Amit M.; Oaknin, Ana; Ray-Coquard, Isabelle; Tinker, Anna V.; Helman, Elena; Radke, Marc R.; Say, Carmen; Vo, Lan-Thanh; Mann, Elaina; Isaacson, Jeffrey D.; Maloney, Lara; O’Malley, David M.; Chambers, Setsuko K.; Kaufmann, Scott H., 0000-0002-4900-7145; Scott, Clare L.; Konecny, Gottfried E.; Coleman, Robert L.; Sun, James X.; Giordano, Heidi; Brenton, James D., 0000-0002-5738-6683; Harding, Thomas C.; Mcneish, Iain A., 0000-0002-9387-7586; Swisher, Elizabeth M. Cancer Discovery 2018
19536 10.1158/2159-8290.cd-18-1020 Targeting Dna Damage Response Promotes Antitumor Immunity Through Sting-Mediated T-Cell Activation In Small Cell Lung Cancer Sen, Triparna; Rodriguez, B. Leticia; Chen, Limo; Corte, Carminia M. Della; Morikawa, Naoto; Fujimoto, Junya; Cristea, Sandra; Nguyen, Thuyen; Diao, Lixia; Li, Lerong; Fan, Youhong; Yang, Yongbin; Wang, Jing; Glisson, Bonnie S.; Wistuba, Ignacio I.; Sage, Julien, 0000-0002-8928-9968; Heymach, John V., 0000-0001-9068-8942; Gibbons, Don L.; Byers, Lauren A. Cancer Discovery 2019
19537 10.1158/2159-8290.cd-18-1022 Landscape Of Acquired Resistance To Osimertinib In Egfr-Mutant Nsclc And Clinical Validation Of Combined Egfr And Ret Inhibition With Osimertinib And Blu-667 For Acquired Ret Fusion Piotrowska, Zofia; Isozaki, Hideko; Lennerz, Jochen K.; Gainor, Justin F.; Lennes, Inga T.; Zhu, Viola W.; Marcoux, Nicolas, 0000-0003-1422-6716; Banwait, Mandeep K.; Digumarthy, Subba R.; Su, Wenjia; Yoda, Satoshi, 0000-0003-4201-1392; Riley, Amanda K.; Nangia, Varuna; Lin, Jessica J., 0000-0001-7373-3916; Nagy, Rebecca J.; Lanman, Richard B., 0000-0001-8122-4329; Dias-Santagata, Dora; Mino-Kenudson, Mari; Iafrate, A. John; Heist, Rebecca S.; Shaw, Alice T.; Evans, Erica K.; Clifford, Corinne; Ou, Sai-Hong I.; Wolf, Beni; Hata, Aaron N.; Sequist, Lecia V., 0000-0002-8965-6991 Cancer Discovery 2018
19539 10.1158/2159-8290.cd-18-1218 Parp Inhibitor Efficacy Depends On Cd8+ T-Cell Recruitment Via Intratumoral Sting Pathway Activation In Brca-Deficient Models Of Triple-Negative Breast Cancer Pantelidou, Constantia; Sonzogni, Olmo, 0000-0001-5697-8102; De Oliveria Taveira, Mateus; Mehta, Anita K.; Kothari, Aditi; Wang, Dan; Visal, Tanvi; Li, Michelle K.; Pinto, Jocelin; Castrillon, Jessica A.; Cheney, Emily M.; Bouwman, Peter; Jonkers, Jos, 0000-0002-9264-9792; Rottenberg, Sven; Guerriero, Jennifer L., 0000-0002-2104-5457; Wulf, Gerburg M.; Shapiro, Geoffrey I. Cancer Discovery 2019
19551 10.1158/2159-8290.cd-19-0582 Combination Olaparib And Temozolomide In Relapsed Small-Cell Lung Cancer Farago, Anna F.; Yeap, Beow Y.; Stanzione, Marcello; Hung, Yin P., 0000-0002-8568-1591; Heist, Rebecca S.; Marcoux, J. Paul; Zhong, Jun; Rangachari, Deepa; Barbie, David A.; Phat, Sarah; Myers, David T.; Morris, Robert; Kem, Marina; Dubash, Taronish D.; Kennedy, Elizabeth A.; Digumarthy, Subba R., 0000-0003-4041-6716; Sequist, Lecia V., 0000-0002-8965-6991; Hata, Aaron N.; Maheswaran, Shyamala; Haber, Daniel A.; Lawrence, Michael S.; Shaw, Alice T.; Mino-Kenudson, Mari, 0000-0002-9092-2265; Dyson, Nicholas J.; Drapkin, Benjamin J. Cancer Discovery 2019
19558 10.1158/2159-8290.cd-19-1014 Targeting Her2 With Trastuzumab Deruxtecan: A Dose-Expansion, Phase I Study In Multiple Advanced Solid Tumors Tsurutani, Junji, 0000-0002-6260-6943; Iwata, Hiroji, 0000-0002-0242-4718; Krop, Ian; Janne, Pasi A.; Doi, Toshihiko; Takahashi, Shunji; Park, Haeseong; Redfern, Charles; Tamura, Kenji, 0000-0002-3514-9927; Wise-Draper, Trisha M.; Saito, Kaku; Sugihara, Masahiro; Singh, Jasmeet; Jikoh, Takahiro; Gallant, Gilles; Li, Bob T., 0000-0001-6661-8733 Cancer Discovery 2020
19748 10.1172/jci123319 Parp Inhibition Enhances Tumor Cell<U+2013>Intrinsic Immunity In Ercc1-Deficient Non<U+2013>Small Cell Lung Cancer Chabanon, Roman M.; Muirhead, Gareth; Krastev, Dragomir B., 0000-0003-4298-7272; Adam, Julien; Morel, Daphne, 0000-0002-9121-4973; Garrido, Marlene, 0000-0001-7492-0879; Lamb, Andrew; Henon, Clemence; Dorvault, Nicolas; Rouanne, Mathieu, 0000-0003-2970-4821; Marlow, Rebecca, 0000-0001-7525-7968; Bajrami, Ilirjana; Cardenosa, Marta Llorca; Konde, Asha; Besse, Benjamin; Ashworth, Alan; Pettitt, Stephen J., 0000-0003-3313-3857; Haider, Syed; Marabelle, Aurelien, 0000-0002-5816-3019; Tutt, Andrew N.J., 0000-0001-8715-2901; Soria, Jean-Charles; Lord, Christopher J., 0000-0002-3226-0515; Postel-Vinay, Sophie Journal Of Clinical Investigation 2019
20016 10.1186/s12885-019-5380-3 Safety And Antitumor Activity Of The Anti<U+2013>Pd-1 Antibody Pembrolizumab In Patients With Advanced, Pd-L1<U+2013>Positive Papillary Or Follicular Thyroid Cancer Mehnert, Janice M.; Varga, Andrea; Brose, Marcia S.; Aggarwal, Rahul R.; Lin, Chia-Chi; Prawira, Amy; De Braud, Filippo; Tamura, Kenji; Doi, Toshihiko; Piha-Paul, Sarina A.; Gilbert, Jill; Saraf, Sanatan; Thanigaimani, Pradeep; Cheng, Jonathan D.; Keam, Bhumsuk Bmc Cancer 2019
20190 10.1186/s40425-019-0514-3 Clinicopathological And Molecular Features Of Responders To Nivolumab For Patients With Advanced Gastric Cancer Mishima, Saori; Kawazoe, Akihito; Nakamura, Yoshiaki; Sasaki, Akinori; Kotani, Daisuke; Kuboki, Yasutoshi; Bando, Hideaki; Kojima, Takashi; Doi, Toshihiko; Ohtsu, Atsushi; Yoshino, Takayuki; Kuwata, Takeshi; Tsuji, Akihito; Shitara, Kohei Journal For Immunotherapy Of Cancer 2019
20212 10.1200/jco.18.00131 Select: A Phase Ii Trial Of Adjuvant Erlotinib In Patients With Resected Epidermal Growth Factor Receptor<U+2013>Mutant Non<U+2013>Small-Cell Lung Cancer Pennell, Nathan A.; Neal, Joel W.; Chaft, Jamie E.; Azzoli, Christopher G.; Janne, Pasi A.; Govindan, Ramaswamy; Evans, Tracey L.; Costa, Daniel B.; Wakelee, Heather A.; Heist, Rebecca S.; Shapiro, Marc A.; Muzikansky, Alona; Murthy, Sudish; Lanuti, Michael; Rusch, Valerie W.; Kris, Mark G.; Sequist, Lecia V. Journal Of Clinical Oncology 2019
20214 10.1200/jco.18.00264 Randomized Phase Ii Trial Of Cisplatin And Etoposide In Combination With Veliparib Or Placebo For Extensive-Stage Small-Cell Lung Cancer: Ecog-Acrin 2511 Study Owonikoko, Taofeek K.; Dahlberg, Suzanne E.; Sica, Gabriel L.; Wagner, Lynne I.; Wade, James L.; Srkalovic, Gordan; Lash, Bradley W.; Leach, Joseph W.; Leal, Ticiana B.; Aggarwal, Charu; Ramalingam, Suresh S. Journal Of Clinical Oncology 2019
20221 10.1200/jco.18.01010 Tumor-Infiltrating Lymphocytes And Prognosis: A Pooled Individual Patient Analysis Of Early-Stage Triple-Negative Breast Cancers Loi, Sherene; Drubay, Damien; Adams, Sylvia; Pruneri, Giancarlo; Francis, Prudence A.; Lacroix-Triki, Magali; Joensuu, Heikki; Dieci, Maria Vittoria; Badve, Sunil; Demaria, Sandra; Gray, Robert; Munzone, Elisabetta; Lemonnier, Jerome; Sotiriou, Christos; Piccart, Martine J.; Kellokumpu-Lehtinen, Pirkko-Liisa; Vingiani, Andrea; Gray, Kathryn; Andre, Fabrice; Denkert, Carsten; Salgado, Roberto; Michiels, Stefan Journal Of Clinical Oncology 2019
20226 10.1200/jco.18.01511 Tbcrc 022: A Phase Ii Trial Of Neratinib And Capecitabine For Patients With Human Epidermal Growth Factor Receptor 2<U+2013>Positive Breast Cancer And Brain Metastases Journal Of Clinical Oncology 2019
20227 10.1200/jco.18.01568 Randomized Trial Of Intravenous Versus Intraperitoneal Chemotherapy Plus Bevacizumab In Advanced Ovarian Carcinoma: An Nrg Oncology/Gynecologic Oncology Group Study Walker, Joan L.; Brady, Mark F.; Wenzel, Lari; Fleming, Gini F.; Huang, Helen Q.; Disilvestro, Paul A.; Fujiwara, Keiichi; Alberts, David S.; Zheng, Wenxin; Tewari, Krishnansu S.; Cohn, David E.; Powell, Matthew A.; Van Le, Linda; Davidson, Susan A.; Gray, Heidi J.; Rose, Peter G.; Aghajanian, Carol; Myers, Tashanna; Alvarez Secord, Angeles; Rubin, Stephen C.; Mannel, Robert S. Journal Of Clinical Oncology 2019
20231 10.1200/jco.18.01585 Egfr-Mutant Adenocarcinomas That Transform To Small-Cell Lung Cancer And Other Neuroendocrine Carcinomas: Clinical Outcomes Journal Of Clinical Oncology 2019
20236 10.1200/jco.18.02236 Alk Resistance Mutations And Efficacy Of Lorlatinib In Advanced Anaplastic Lymphoma Kinase-Positive Non<U+2013>Small-Cell Lung Cancer Shaw, Alice T.; Solomon, Benjamin J.; Besse, Benjamin; Bauer, Todd M.; Lin, Chia-Chi; Soo, Ross A.; Riely, Gregory J.; Ou, Sai-Hong Ignatius; Clancy, Jill S.; Li, Sherry; Abbattista, Antonello; Thurm, Holger; Satouchi, Miyako; Camidge, D. Ross; Kao, Steven; Chiari, Rita; Gadgeel, Shirish M.; Felip, Enriqueta; Martini, Jean-Francois Journal Of Clinical Oncology 2019
20240 10.1200/jco.19.00066 Seven-Year Follow-Up Analysis Of Adjuvant Paclitaxel And Trastuzumab Trial For Node-Negative, Human Epidermal Growth Factor Receptor 2<U+2013>Positive Breast Cancer Tolaney, Sara M.; Guo, Hao; Pernas, Sonia; Barry, William T.; Dillon, Deborah A.; Ritterhouse, Lauren; Schneider, Bryan P.; Shen, Fei; Fuhrman, Kit; Baltay, Michele; Dang, Chau T.; Yardley, Denise A.; Moy, Beverly; Marcom, P. Kelly; Albain, Kathy S.; Rugo, Hope S.; Ellis, Mathew J.; Shapira, Iuliana; Wolff, Antonio C.; Carey, Lisa A.; Overmoyer, Beth; Partridge, Ann H.; Hudis, Clifford A.; Krop, Ian E.; Burstein, Harold J.; Winer, Eric P. Journal Of Clinical Oncology 2019
20241 10.1200/jco.19.00075 Erlotinib Versus Gemcitabine Plus Cisplatin As Neoadjuvant Treatment Of Stage Iiia-N2 Egfr-Mutant Non<U+2013>Small-Cell Lung Cancer (Emerging-Ctong 1103): A Randomized Phase Ii Study Zhong, Wen-Zhao; Chen, Ke-Neng; Chen, Chun; Gu, Chun-Dong; Wang, Jun; Yang, Xue-Ning; Mao, Wei-Min; Wang, Qun; Qiao, Gui-Bin; Cheng, Ying; Xu, Lin; Wang, Chang-Li; Chen, Ming-Wei; Kang, Xiaozheng; Yan, Wanpu; Yan, Hong-Hong; Liao, Ri-Qiang; Yang, Jin-Ji; Zhang, Xu-Chao; Zhou, Qing; Wu, Yi-Long Journal Of Clinical Oncology 2019
20242 10.1200/jco.19.00108 Pyrotinib Or Lapatinib Combined With Capecitabine In Her2<U+2013>Positive Metastatic Breast Cancer With Prior Taxanes, Anthracyclines, And/Or Trastuzumab: A Randomized, Phase Ii Study Ma, Fei; Ouyang, Quchang; Li, Wei; Jiang, Zefei; Tong, Zhongsheng; Liu, Yunjiang; Li, Huiping; Yu, Shiying; Feng, Jifeng; Wang, Shusen; Hu, Xichun; Zou, Jianjun; Zhu, Xiaoyu; Xu, Binghe Journal Of Clinical Oncology 2019
20249 10.1200/jco.19.00457 Osimertinib In Patients With Epidermal Growth Factor Receptor Mutation<U+2013>Positive Non<U+2013>Small-Cell Lung Cancer And Leptomeningeal Metastases: The Bloom Study Yang, James C.H.; Kim, Sang-We; Kim, Dong-Wan; Lee, Jong-Seok; Cho, Byoung Chul; Ahn, Jin-Seok; Lee, Dae H.; Kim, Tae Min; Goldman, Jonathan W.; Natale, Ronald B.; Brown, Andrew P.; Collins, Barbara; Chmielecki, Juliann; Vishwanathan, Karthick; Mendoza-Naranjo, Ariadna; Ahn, Myung-Ju Journal Of Clinical Oncology 2020
20252 10.1200/jco.19.00882 Neoadjuvant Trastuzumab Emtansine And Pertuzumab In Human Epidermal Growth Factor Receptor 2<U+2013>Positive Breast Cancer: Three-Year Outcomes From The Phase Iii Kristine Study Hurvitz, Sara A.; Martin, Miguel; Jung, Kyung Hae; Huang, Chiun-Sheng; Harbeck, Nadia; Valero, Vicente; Stroyakovskiy, Daniil; Wildiers, Hans; Campone, Mario; Boileau, Jean-Francois; Fasching, Peter A.; Afenjar, Karen; Spera, Gonzalo; Lopez-Valverde, Vanesa; Song, Chunyan; Trask, Peter; Boulet, Thomas; Sparano, Joseph A.; Symmans, W. Fraser; Thompson, Alastair M.; Slamon, Dennis Journal Of Clinical Oncology 2019
20254 10.1200/jco.19.00931 Osimertinib For Patients With Non<U+2013>Small-Cell Lung Cancer Harboring Uncommon Egfr Mutations: A Multicenter, Open-Label, Phase Ii Trial (Kcsg-Lu15-09) Cho, Jang Ho; Lim, Sung Hee; An, Ho Jung; Kim, Ki Hwan; Park, Keon Uk; Kang, Eun Joo; Choi, Yoon Hee; Ahn, Mi Sun; Lee, Myung Hee; Sun, Jong-Mu; Lee, Se-Hoon; Ahn, Jin Seok; Park, Keunchil; Ahn, Myung-Ju Journal Of Clinical Oncology 2020
20255 10.1200/jco.19.01009 Final Overall Survival Of A Randomized Trial Of Bevacizumab For Primary Treatment Of Ovarian Cancer Tewari, Krishnansu S.; Burger, Robert A.; Enserro, Danielle; Norquist, Barbara M.; Swisher, Elizabeth M.; Brady, Mark F.; Bookman, Michael A.; Fleming, Gini F.; Huang, Helen; Homesley, Howard D.; Fowler, Jeffrey M.; Greer, Benjamin E.; Boente, Matthew; Liang, Sharon X.; Ye, Chenglin; Bais, Carlos; Randall, Leslie M.; Chan, John K.; Ferriss, J. Stuart; Coleman, Robert L.; Aghajanian, Carol; Herzog, Thomas J.; Disaia, Philip J.; Copeland, Larry J.; Mannel, Robert S.; Birrer, Michael J.; Monk, Bradley J. Journal Of Clinical Oncology 2019
20258 10.1200/jco.19.01154 Gefitinib Versus Gefitinib Plus Pemetrexed And Carboplatin Chemotherapy In Egfr-Mutated Lung Cancer Noronha, Vanita; Patil, Vijay Maruti; Joshi, Amit; Menon, Nandini; Chougule, Anuradha; Mahajan, Abhishek; Janu, Amit; Purandare, Nilendu; Kumar, Rajiv; More, Sucheta; Goud, Supriya; Kadam, Nandkumar; Daware, Nilesh; Bhattacharjee, Atanu; Shah, Srushti; Yadav, Akanksha; Trivedi, Vaishakhi; Behel, Vichitra; Dutt, Amit; Banavali, Shripad Dinanath; Prabhash, Kumar Journal Of Clinical Oncology 2020
20261 10.1200/jco.19.01304 Neoadjuvant Talazoparib For Patients With Operable Breast Cancer With A Germline Brca Pathogenic Variant Litton, Jennifer K.; Scoggins, Marion E.; Hess, Kenneth R.; Adrada, Beatriz E.; Murthy, Rashmi K.; Damodaran, Senthil; Desnyder, Sarah M.; Brewster, Abenaa M.; Barcenas, Carlos H.; Valero, Vicente; Whitman, Gary J.; Schwartz-Gomez, Jill; Mittendorf, Elizabeth A.; Thompson, Alastair M.; Helgason, Thorunn; Ibrahim, Nuhad; Piwnica-Worms, Helen; Moulder, Stacy L.; Arun, Banu K. Journal Of Clinical Oncology 2020
20263 10.1200/jco.19.01455 Nsabp B-47/Nrg Oncology Phase Iii Randomized Trial Comparing Adjuvant Chemotherapy With Or Without Trastuzumab In High-Risk Invasive Breast Cancer Negative For Her2 By Fish And With Ihc 1+ Or 2+ Fehrenbacher, Louis; Cecchini, Reena S.; Geyer Jr, Charles E.; Rastogi, Priya; Costantino, Joseph P.; Atkins, James N.; Crown, John P.; Polikoff, Jonathan; Boileau, Jean-Francois; Provencher, Louise; Stokoe, Christopher; Moore, Timothy D.; Robidoux, Andre; Flynn, Patrick J.; Borges, Virginia F.; Albain, Kathy S.; Swain, Sandra M.; Paik, Soonmyung; Mamounas, Eleftherios P.; Wolmark, Norman Journal Of Clinical Oncology 2020
20266 10.1200/jco.19.01488 Gefitinib Alone Versus Gefitinib Plus Chemotherapy For Non<U+2013>Small-Cell Lung Cancer With Mutated Epidermal Growth Factor Receptor: Nej009 Study Hosomi, Yukio; Morita, Satoshi; Sugawara, Shunichi; Kato, Terufumi; Fukuhara, Tatsuro; Gemma, Akihiko; Takahashi, Kazuhisa; Fujita, Yuka; Harada, Toshiyuki; Minato, Koichi; Takamura, Kei; Hagiwara, Koichi; Kobayashi, Kunihiko; Nukiwa, Toshihiro; Inoue, Akira Journal Of Clinical Oncology 2020
20271 10.1200/jco.19.02059 Randomized Phase Ii Trial Of Nivolumab Versus Nivolumab And Ipilimumab For Recurrent Or Persistent Ovarian Cancer: An Nrg Oncology Study Zamarin, Dmitriy; Burger, Robert A.; Sill, Michael W.; Powell, Daniel J.; Lankes, Heather A.; Feldman, Michael D.; Zivanovic, Oliver; Gunderson, Camille; Ko, Emily; Mathews, Cara; Sharma, Sudarshan; Hagemann, Andrea R.; Khleif, Samir; Aghajanian, Carol Journal Of Clinical Oncology 2020
20275 10.1200/jco.19.02318 Antitumor Activity And Safety Of Trastuzumab Deruxtecan In Patients With Her2-Low<U+2013>Expressing Advanced Breast Cancer: Results From A Phase Ib Study Modi, Shanu; Park, Haeseong; Murthy, Rashmi K.; Iwata, Hiroji; Tamura, Kenji; Tsurutani, Junji; Moreno-Aspitia, Alvaro; Doi, Toshihiko; Sagara, Yasuaki; Redfern, Charles; Krop, Ian E.; Lee, Caleb; Fujisaki, Yoshihiko; Sugihara, Masahiro; Zhang, Lin; Shahidi, Javad; Takahashi, Shunji Journal Of Clinical Oncology 2020
20276 10.1200/jco.19.02551 State-Of-The-Art Strategies For Targeting Ret-Dependent Cancers Subbiah, Vivek; Yang, Dong; Velcheti, Vamsidhar; Drilon, Alexander; Meric-Bernstam, Funda Journal Of Clinical Oncology 2020
20278 10.1200/jco.19.02727 Pd-1 Blockade In Anaplastic Thyroid Carcinoma Capdevila, Jaume; Wirth, Lori J.; Ernst, Thomas; Ponce Aix, Santiago; Lin, Chia-Chi; Ramlau, Rodryg; Butler, Marcus O.; Delord, Jean-Pierre; Gelderblom, Hans; Ascierto, Paolo A.; Fasolo, Angelica; Fuhrer, Dagmar, 0000-0003-0357-4192; Hutter-Kronke, Marie Luise; Forde, Patrick M.; Wrona, Anna; Santoro, Armando; Sadow, Peter M.; Szpakowski, Sebastian; Wu, Hongqian; Bostel, Geraldine; Faris, Jason; Cameron, Scott; Varga, Andreea; Taylor, Matthew Journal Of Clinical Oncology 2020
20279 10.1200/jco.19.02745 Olaparib Versus Nonplatinum Chemotherapy In Patients With Platinum-Sensitive Relapsed Ovarian Cancer And A Germline Brca1/2 Mutation (Solo3): A Randomized Phase Iii Trial Penson, Richard T.; Valencia, Ricardo Villalobos; Cibula, David; Colombo, Nicoletta; Leath, Charles A.; Bidzi<U+0144>ski, Mariusz; Kim, Jae-Weon; Nam, Joo Hyun; Madry, Radoslaw; Hernandez, Carlos; Mora, Paulo A.R.; Ryu, Sang Young; Milenkova, Tsveta; Lowe, Elizabeth S.; Barker, Laura; Scambia, Giovanni Journal Of Clinical Oncology 2020
20287 10.1200/jco.20.00147 Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine In Her2-Positive Metastatic Breast Cancer Previously Treated With <U+2265> 2 Her2-Directed Regimens: Phase Iii Nala Trial Saura, Cristina; Oliveira, Mafalda; Feng, Yin-Hsun; Dai, Ming-Shen; Chen, Shang-Wen; Hurvitz, Sara A.; Kim, Sung-Bae; Moy, Beverly; Delaloge, Suzette; Gradishar, William; Masuda, Norikazu; Palacova, Marketa; Trudeau, Maureen E.; Mattson, Johanna; Yap, Yoon Sim; Hou, Ming-Feng; De Laurentiis, Michelino; Yeh, Yu-Min; Chang, Hong-Tai; Yau, Thomas; Wildiers, Hans; Haley, Barbara; Fagnani, Daniele; Lu, Yen-Shen; Crown, John; Lin, Johnson; Takahashi, Masato; Takano, Toshimi; Yamaguchi, Miki; Fujii, Takaaki; Yao, Bin; Bebchuk, Judith; Keyvanjah, Kiana; Bryce, Richard; Brufsky, Adam Journal Of Clinical Oncology 2020
20289 10.1200/jco.20.00505 Brigatinib Versus Crizotinib In Advanced Alk Inhibitor<U+2013>Naive Alk-Positive Non<U+2013>Small Cell Lung Cancer: Second Interim Analysis Of The Phase Iii Alta-1L Trial Camidge, D. Ross; Kim, Hye Ryun; Ahn, Myung-Ju; Yang, James C. H.; Han, Ji-Youn; Hochmair, Maximilian J.; Lee, Ki Hyeong; Delmonte, Angelo; Garcia Campelo, Maria Rosario; Kim, Dong-Wan; Griesinger, Frank; Felip, Enriqueta; Califano, Raffaele; Spira, Alexander; Gettinger, Scott N.; Tiseo, Marcello; Lin, Huamao M.; Gupta, Neeraj; Hanley, Michael J.; Ni, Quanhong; Zhang, Pingkuan; Popat, Sanjay Journal Of Clinical Oncology 2020
20292 10.1200/jco.20.00775 Intracranial Efficacy And Survival With Tucatinib Plus Trastuzumab And Capecitabine For Previously Treated Her2-Positive Breast Cancer With Brain Metastases In The Her2Climb Trial Journal Of Clinical Oncology 2020
20300 10.1200/jco.20.01888 Randomized Phase Iii Keynote-181 Study Of Pembrolizumab Versus Chemotherapy In Advanced Esophageal Cancer Kojima, Takashi, 0000-0002-2554-8334; Shah, Manish A., 0000-0002-6913-9655; Muro, Kei; Francois, Eric; Adenis, Antoine; Hsu, Chih-Hung; Doi, Toshihiko, 0000-0003-2042-6829; Moriwaki, Toshikazu, 0000-0001-7702-122X; Kim, Sung-Bae, 0000-0001-5588-8332; Lee, Se-Hoon, 0000-0002-9219-3350; Bennouna, Jaafar; Kato, Ken, 0000-0002-1733-5072; Shen, Lin, 0000-0002-8798-4756; Enzinger, Peter; Qin, Shu-Kui, 0000-0003-2289-1521; Ferreira, Paula; Chen, Jia; Girotto, Gustavo, 0000-0002-4098-1320; De La Fouchardiere, Christelle, 0000-0003-2291-5693; Senellart, Helene; Al-Rajabi, Raed; Lordick, Florian; Wang, Ruixue; Suryawanshi, Shailaja; Bhagia, Pooja; Kang, S. Peter; Metges, Jean-Philippe Journal Of Clinical Oncology 2020
20302 10.1200/jco.20.02151 Tbcrc 048: Phase Ii Study Of Olaparib For Metastatic Breast Cancer And Mutations In Homologous Recombination-Related Genes Journal Of Clinical Oncology 2020
20307 10.1200/jco.2017.76.6212 Checkmate-032 Study: Efficacy And Safety Of Nivolumab And Nivolumab Plus Ipilimumab In Patients With Metastatic Esophagogastric Cancer Janjigian, Yelena Y.; Bendell, Johanna; Calvo, Emiliano; Kim, Joseph W.; Ascierto, Paolo A.; Sharma, Padmanee; Ott, Patrick A.; Peltola, Katriina; Jaeger, Dirk; Evans, Jeffry; De Braud, Filippo; Chau, Ian; Harbison, Christopher T.; Dorange, Cecile; Tschaika, Marina; Le, Dung T. Journal Of Clinical Oncology 2018
20310 10.1200/jco.2017.77.4794 Final Overall Survival Analysis From A Study Comparing First-Line Crizotinib Versus Chemotherapy In Alk-Mutation-Positive Non<U+2013>Small-Cell Lung Cancer Solomon, Benjamin J.; Kim, Dong-Wan; Wu, Yi-Long; Nakagawa, Kazuhiko; Mekhail, Tarek; Felip, Enriqueta; Cappuzzo, Federico; Paolini, Jolanda; Usari, Tiziana; Tang, Yiyun; Wilner, Keith D.; Blackhall, Fiona; Mok, Tony S. Journal Of Clinical Oncology 2018
20313 10.1200/jco.2018.77.7326 Phase Ib/Ii Study Of Capmatinib (Inc280) Plus Gefitinib After Failure Of Epidermal Growth Factor Receptor (Egfr) Inhibitor Therapy In Patients With Egfr-Mutated, Met Factor<U+2013>Dysregulated Non<U+2013>Small-Cell Lung Cancer Wu, Yi-Long; Zhang, Li; Kim, Dong-Wan; Liu, Xiaoqing; Lee, Dae Ho; Yang, James Chih-Hsin; Ahn, Myung-Ju; Vansteenkiste, Johan F.; Su, Wu-Chou; Felip, Enriqueta; Chia, Vincent; Glaser, Sabine; Pultar, Philippe; Zhao, Sylvia; Peng, Bin; Akimov, Mikhail; Tan, Daniel S.W. Journal Of Clinical Oncology 2018
20314 10.1200/jco.2018.77.7672 Randomized, Double-Blind, Phase Ii Study Of Temozolomide In Combination With Either Veliparib Or Placebo In Patients With Relapsed-Sensitive Or Refractory Small-Cell Lung Cancer Pietanza, M. Catherine; Waqar, Saiama N.; Krug, Lee M.; Dowlati, Afshin; Hann, Christine L.; Chiappori, Alberto; Owonikoko, Taofeek K.; Woo, Kaitlin M.; Cardnell, Robert J.; Fujimoto, Junya; Long, Lihong; Diao, Lixia; Wang, Jing; Bensman, Yevgeniva; Hurtado, Brenda; De Groot, Patricia; Sulman, Erik P.; Wistuba, Ignacio I.; Chen, Alice; Fleisher, Martin; Heymach, John V.; Kris, Mark G.; Rudin, Charles M.; Byers, Lauren Averett Journal Of Clinical Oncology 2018
20316 10.1200/jco.2018.77.9363 Cns Efficacy Of Osimertinib In Patients With T790M-Positive Advanced Non<U+2013>Small-Cell Lung Cancer: Data From A Randomized Phase Iii Trial (Aura3) Wu, Yi-Long; Ahn, Myung-Ju; Garassino, Marina Chiara; Han, Ji-Youn; Katakami, Nobuyuki; Kim, Hye Ryun; Hodge, Rachel; Kaur, Paramjit; Brown, Andrew P.; Ghiorghiu, Dana; Papadimitrakopoulou, Vassiliki A.; Mok, Tony S.K. Journal Of Clinical Oncology 2018
20317 10.1200/jco.2018.77.9777 Ado-Trastuzumab Emtansine For Patients With Her2-Mutant Lung Cancers: Results From A Phase Ii Basket Trial Li, Bob T.; Shen, Ronglai; Buonocore, Darren; Olah, Zachary T.; Ni, Ai; Ginsberg, Michelle S.; Ulaner, Gary A.; Offin, Michael; Feldman, Daniel; Hembrough, Todd; Cecchi, Fabiola; Schwartz, Sarit; Pavlakis, Nick; Clarke, Stephen; Won, Helen H.; Brzostowski, Edyta B.; Riely, Gregory J.; Solit, David B.; Hyman, David M.; Drilon, Alexander; Rudin, Charles M.; Berger, Michael F.; Baselga, Jose; Scaltriti, Maurizio; Arcila, Maria E.; Kris, Mark G. Journal Of Clinical Oncology 2018
20318 10.1200/jco.2018.78.3118 Cns Response To Osimertinib Versus Standard Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors In Patients With Untreated Egfr-Mutated Advanced Non<U+2013>Small-Cell Lung Cancer Reungwetwattana, Thanyanan; Nakagawa, Kazuhiko; Cho, Byoung Chul; Cobo, Manuel; Cho, Eun Kyung; Bertolini, Alessandro; Bohnet, Sabine; Zhou, Caicun; Lee, Ki Hyeong; Nogami, Naoyuki; Okamoto, Isamu; Leighl, Natasha; Hodge, Rachel; Mckeown, Astrid; Brown, Andrew P.; Rukazenkov, Yuri; Ramalingam, Suresh S.; Vansteenkiste, Johan Journal Of Clinical Oncology 2018
20323 10.1200/jco.2019.37.15_suppl.1000 Sophia Primary Analysis: A Phase 3 (P3) Study Of Margetuximab (M) + Chemotherapy (C) Versus Trastuzumab (T) + C In Patients (Pts) With Her2+ Metastatic (Met) Breast Cancer (Mbc) After Prior Anti-Her2 Therapies (Tx). Rugo, Hope S.; Im, Seock-Ah; Wright, Gail Lynn Shaw; Escriva-De-Romani, Santiago; Delaurentiis, Michelino; Cortes, Javier; Bahadur, Shakeela Wazeen; Haley, Barbara B.; Oyola, Raul H.; Riseberg, David A.; Musolino, Antonino; Cardoso, Fatima; Curigliano, Giuseppe; Kaufman, Peter A.; Pegram, Mark D.; Edlich, Sutton; Hong, Sam; Rock, Edwin P.; Gradishar, William John Journal Of Clinical Oncology 2019
20324 10.1200/jco.2019.37.15_suppl.1002 Neratinib + Capecitabine Versus Lapatinib + Capecitabine In Patients With Her2+ Metastatic Breast Cancer Previously Treated With <U+2265> 2 Her2-Directed Regimens: Findings From The Multinational, Randomized, Phase Iii Nala Trial. Saura, Cristina; Oliveira, Mafalda; Feng, Yin-Hsun; Dai, Ming-Shen; Hurvitz, Sara A.; Kim, Sung-Bae; Moy, Beverly; Delaloge, Suzette; Gradishar, William John; Masuda, Norikazu; Palacova, Marketa; Trudeau, Maureen E.; Mattson, Johanna; Yap, Yoon Sim; Bryce, Richard; Yao, Bin; Bebchuk, Judith D.; Keyvanjah, Kiana; Brufsky, Adam Journal Of Clinical Oncology 2019
20332 10.1200/jco.2019.37.15_suppl.9004 Wolf, Juergen; Seto, Takashi; Han, Ji-Youn; Reguart, Noemi; Garon, Edward B.; Groen, Harry J.M.; Tan, Daniel Shao-Weng; Hida, Toyoaki; De Jonge, Maja J.; Orlov, Sergey V.; Smit, Egbert F.; Souquet, Pierre Jean; Vansteenkiste, Johan F.; Giovannini, Monica; Le Mouhaer, Sylvie; Robeva, Anna; Waldron-Lynch, Maeve; Heist, Rebecca Suk Journal Of Clinical Oncology 2019
20333 10.1200/jco.2019.37.15_suppl.9008 Clinical Activity And Tolerability Of Blu-667, A Highly Potent And Selective Ret Inhibitor, In Patients (Pts) With Advanced Ret-Fusion+ Non-Small Cell Lung Cancer (Nsclc). Gainor, Justin F.; Lee, Dae Ho; Curigliano, Giuseppe; Doebele, Robert Charles; Kim, Dong-Wan; Baik, Christina S; Tan, Daniel Shao-Weng; Lopes, Gilberto; Gadgeel, Shirish M.; Cassier, Philippe Alexandre; Taylor, Matthew H.; Liu, Stephen V.; Besse, Benjamin; Thomas, Michael; Zhu, Viola Weijia; Zhang, Hui; Clifford, Corinne; Palmer, Michael; Turner, Christopher D.; Subbiah, Vivek Journal Of Clinical Oncology 2019
20334 10.1200/jco.2019.37.18_suppl.lba4007 Pembrolizumab With Or Without Chemotherapy Versus Chemotherapy For Advanced Gastric Or Gastroesophageal Junction (G/Gej) Adenocarcinoma: The Phase Iii Keynote-062 Study. Tabernero, Josep; Van Cutsem, Eric; Bang, Yung-Jue; Fuchs, Charles S.; Wyrwicz, Lucjan; Lee, Keun Wook; Kudaba, Iveta; Garrido, Marcelo; Chung, Hyun Cheol; Castro Salguero, Hugo Raul; Mansoor, Wasat; Braghiroli, Maria Ignez Freitas Melro; Goekkurt, Eray; Chao, Joseph; Wainberg, Zev A.; Kher, Uma; Shah, Sukrut; Kang, Soonmo Peter; Shitara, Kohei Journal Of Clinical Oncology 2019
20337 10.1200/jco.2019.37.4_suppl.2 Pembrolizumab Versus Chemotherapy As Second-Line Therapy For Advanced Esophageal Cancer: Phase Iii Keynote-181 Study. Kojima, Takashi; Muro, Kei; Francois, Eric; Hsu, Chih-Hung; Moriwaki, Toshikazu; Kim, Sung-Bae; Lee, Se-Hoon; Bennouna, Jaafar; Kato, Ken; Lin, Shen; Qin, Shi-Qui; Ferreira, Paula; Doi, Toshihiko; Adenis, Antoine; Enzinger, Peter C.; Shah, Manish A.; Wang, Ruixue; Bhagia, Pooja; Kang, S. Peter; Metges, Jean-Philippe Journal Of Clinical Oncology 2019
20341 10.1200/jco.2020.38.15_suppl.1000 Keynote-355: Randomized, Double-Blind, Phase Iii Study Of Pembrolizumab + Chemotherapy Versus Placebo + Chemotherapy For Previously Untreated Locally Recurrent Inoperable Or Metastatic Triple-Negative Breast Cancer. Cortes, Javier; Cescon, David W.; Rugo, Hope S.; Nowecki, Zbigniew; Im, Seock-Ah; Yusof, Mastura Md; Gallardo, Carlos; Lipatov, Oleg; Barrios, Carlos Henrique; Holgado, Esther; Iwata, Hiroji; Masuda, Norikazu; Torregroza Otero, Marco; Gokmen, Erhan; Loi, Sherene; Guo, Zifang; Zhao, Jing; Aktan, Gursel; Karantza, Vassiliki; Schmid, Peter Journal Of Clinical Oncology 2020
20349 10.1200/jco.2020.38.15_suppl.9504 Trastuzumab Deruxtecan (T-Dxd; Ds-8201) In Patients With Her2-Mutated Metastatic Non-Small Cell Lung Cancer (Nsclc): Interim Results Of Destiny-Lung01. Smit, Egbert F.; Nakagawa, Kazuhiko; Nagasaka, Misako; Felip, Enriqueta; Goto, Yasushi; Li, Bob T.; Pacheco, Jose Maria; Murakami, Haruyasu; Barlesi, Fabrice; Saltos, Andreas Nicholas; Perol, Maurice; Udagawa, Hibiki; Saxena, Kapil; Shiga, Ryota; Guevara, Ferdinand M.; Acharyya, Suddhasatta; Shahidi, Javad; Planchard, David; Janne, Pasi A. Journal Of Clinical Oncology 2020
20434 10.1248/cpb.c18-00744 The Latest Research And Development Into The Antibody<U+2013>Drug Conjugate, [Fam-] Trastuzumab Deruxtecan (Ds-8201A), For Her2 Cancer Therapy Nakada, Takashi; Sugihara, Kiyoshi; Jikoh, Takahiro; Abe, Yuki; Agatsuma, Toshinori Chemical And Pharmaceutical Bulletin 2019
20621 10.15252/emmm.201809172 A Rad 51 Assay Feasible In Routine Tumor Samples Calls Parp Inhibitor Response Beyond Brca Mutation Embo Molecular Medicine 2018
20812 10.2217/fon-2018-0557 A Phase Ii Study Of The Safety And Efficacy Of Lenvatinib In Patients With Advanced Thyroid Cancer Takahashi, Shunji; Kiyota, Naomi; Yamazaki, Tomoko; Chayahara, Naoko; Nakano, Kenji; Inagaki, Lina; Toda, Kazuhisa; Enokida, Tomohiro; Minami, Hironobu; Imamura, Yoshinori; Fukuda, Naoki; Sasaki, Tatsuya; Suzuki, Takuya; Ikezawa, Hiroki; Dutcus, Corina E; Tahara, Makoto Future Oncology 2019
21179 10.3390/ijms20051115 Her2 Directed Antibody-Drug-Conjugates Beyond T-Dm1 In Breast Cancer Rinnerthaler, Gabriel; Gampenrieder, Simon; Greil, Richard, 0000-0002-4462-3694 International Journal Of Molecular Sciences 2019